Profiles

Bruce Taylor

UTAS Home Prof Bruce Taylor

Bruce Taylor

Professorial Research Fellow
Menzies Institute for Medical Research

Hobart CBD Campuses

+61 3 6226 7765 (phone)

Bruce.Taylor@utas.edu.au

Multiple Sclerosis (MS) is a disease of the central nervous system that affects motor, sensory and cognitive functions. It affects approximately 23,000 Australians, and Tasmanians are seven times more likely to develop it than people living in northern areas like Cairns. Clinical neuroscientist, Professor Bruce Taylor, is working out why.

Unlocking the secrets of the sun

A team of researchers in Tasmania is leading the world in determining the population risk factors for multiple sclerosis. And they need to be. Tasmanians are more likely to develop the disease than people living anywhere else in Australia, and there is no cure.

'MS is a multifactorial illness, which means there is no one cause. A number of factors have been found to contribute including genetics, the environment, responses to common viral triggers, body mass index and smoking.'

'Understanding how these factors interact could help prevent the disease. And we are starting to piece together the puzzle,' said Professor Taylor.

Professor Taylor's research has helped uncover a direct link between sun exposure and MS.

'We now know that attacks of MS are related to low levels of vitamin D. This explains why the disease is so common in Tasmania and other destinations located at a similar distance from the equator.'

'We have also found that cases in environments with different latitudinal gradients can be attributed to genetic factors that inhibit the metabolism of vitamin D.'

The relationship between vitamin D, latitude and sunlight is a significant discovery. It provides the basis for further research into the prevention of MS as well as other diseases.

'A large population study using vitamin D supplements over 20 years could provide incredible insights. Vitamin D might be a factor in other diseases as well,' said Professor Taylor.

Professor Taylor is Chairman of the Australian MS Clinical Research Network directing studies into this puzzling disease. He also sits on the steering committee of the International MS Genetics Consortium. But he says that Tasmania is a perfect place to study the disease.

'Tasmania has a stable and relatively isolated population, and the research participation rate from the Tasmanian community is incredible. Tasmanians want to find a way to slow the progression of this disease, and they want to prevent their children from developing it.'

'MS progresses faster in some people than others and we still don't know why. I am interested in what we can do to intervene, for example, studying the impact of giving vitamin D supplements at the first signs of MS.'

While Professor Taylor's research is concerned with how to slow the progression of the disease, the ultimate goal is to prevent the onset of MS.

'If we could identify the risk factors and reduce them by just 50%, we could potentially stop 2.5 million cases of MS globally.'

By discovering the importance of vitamin D, Professor Taylor and his colleagues are now one step closer.

Bruce Taylor is Professor of Neurological Research University of Tasmania. In 2007 he was appointed as a principal research fellow at the Menzies Institute for Medical Research in Hobart as a 50/50 conjoint position with the Royal Hobart Hospital. Since taking up this position in July 2007, he has established the ongoing Tasmanian Genes and Prevalence study, become an executive member of the Australian & New Zealand MS genes consortium (ANZGENE) funded by MS research Australia and an ARC linkage grant, established the NHMRC funded AUSLONG and AUSLONG2 studies, become an executive member of the Australian & New Zealand NMO study, become a steering committee member of the international MS genetic consortium, and established and obtained funding for the PREvention of MS with Vitamin D Australia & New Zealand (PREVANZ) study funded by MS research Australia ($3.5 million).

Career summary

Biography

Prof Taylor is medical graduate of the University of Tasmania and completed specialist training in Neurology in Western Australia and at the Mayo Clinic USA, returning to Australia in 1996 to begin clinical practice in Neurology in Hobart Tasmania. In 2000 he completed and was awarded an MD from the University of Tasmania in the field of peripheral nerve disease with a focus on multifocal motor neuropathy. In 2004 Prof Taylor accepted his first academic appointment as Associate Professor and Neurologist at the Christchurch School of Medicine University of Otago, New Zealand. Whilst in New Zealand he established the New Zealand MS research interest group and was the Primary Investigator on the NZ HRC funded 'National prevalence study of MS in NZ'.

Research Themes

Prof Taylor's research interests align with one of the University's key research themes of Better Health. His principal areas of research interest are in the field of MS epidemiology including the personal, clinical and genetic factors that are associated with the onset and progression of MS. This involves the development of complex cohort studies and gene environment interaction studies. This body of research has resulted in a unique set of research skills, including significant experience in the development of large multicentre cohort studies of MS as well as significant experience in clinical and genetic MS research. One of the most crucial translations of Prof Taylor's research has been the direct uptake of Vitamin D by significant numbers of MS patients in Australia and overseas.

View more on Professor Bruce Taylor in WARP

Awards

Lifetime achievement award for service to people with MS, Tasmanian MS society, 2005.

Fields of Research

  • Central Nervous System (110903)
  • Epidemiology (111706)
  • Neurology and Neuromuscular Diseases (110904)
  • Peripheral Nervous System (110905)
  • Medical Genetics (excl. Cancer Genetics) (110311)
  • Health, Clinical and Counselling Psychology (170106)
  • Mental Health (111714)
  • Health Economics (140208)
  • Genetics (060499)
  • Rehabilitation and Therapy (excl. Physiotherapy) (110321)
  • Preventive Medicine (111716)
  • Clinical Sciences (110399)
  • Autoimmunity (110703)
  • Health Information Systems (incl. Surveillance) (111711)
  • Cellular Nervous System (110902)
  • Neurogenetics (060410)
  • Immunology (110799)
  • Neurosciences (110999)
  • Cellular Immunology (110704)
  • Infectious Diseases (110309)
  • Genomics (060408)
  • Autonomic Nervous System (110901)
  • Immunogenetics (incl. Genetic Immunology) (110706)
  • Proteins and Peptides (030406)
  • Medical and Health Sciences (119999)
  • Quantitative Genetics (incl. Disease and Trait Mapping Genetics) (060412)
  • Immunological and Bioassay Methods (030104)
  • Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology) (170101)
  • Probability Theory (010404)
  • Anaesthesiology (110301)
  • Innate Immunity (110707)
  • Nutrition and Dietetics (111199)
  • Medical Microbiology (110899)
  • Sensory Systems (110906)
  • Complementary and Alternative Medicine (110499)
  • Basic Pharmacology (111501)
  • Biologically Active Molecules (030401)
  • Public Health and Health Services (111799)
  • Population, Ecological and Evolutionary Genetics (060411)
  • Tumour Immunology (110709)
  • Cell and Nuclear Division (060402)
  • Cell Physiology (111601)
  • Systems Physiology (111603)
  • Pharmacology and Pharmaceutical Sciences (111599)
  • Medical Physiology (111699)

Research Objectives

  • Nervous System and Disorders (920111)
  • Preventive Medicine (920412)
  • Inherited Diseases (incl. Gene Therapy) (920110)
  • Immune System and Allergy (920108)
  • Disease Distribution and Transmission (incl. Surveillance and Response) (920404)
  • Infectious Diseases (920109)
  • Clinical Health (Organs, Diseases and Abnormal Conditions) (920199)
  • Mental Health (920410)
  • Health (929999)
  • Behaviour and Health (920401)
  • Specific Population Health (excl. Indigenous Health) (920599)
  • Expanding Knowledge in the Biological Sciences (970106)
  • Environmental Health (920405)
  • Expanding Knowledge in the Medical and Health Sciences (970111)
  • Cancer and Related Disorders (920102)
  • Neurodegenerative Disorders Related to Ageing (920112)
  • Allied Health Therapies (excl. Mental Health Services) (920201)
  • Diabetes (920104)
  • Human Biological Preventatives (e.g. Vaccines) (860801)
  • Skeletal System and Disorders (incl. Arthritis) (920116)
  • Blood Disorders (920101)
  • Public Health (excl. Specific Population Health) (920499)
  • Human Pharmaceutical Treatments (e.g. Antibiotics) (860803)
  • Human Diagnostics (860802)
  • Expanding Knowledge in Economics (970114)
  • Disability and Functional Capacity (920403)
  • Health and Support Services (920299)
  • Health Policy Evaluation (920208)
  • Health Status (e.g. Indicators of Well-Being) (920408)
  • Expanding Knowledge in Psychology and Cognitive Sciences (970117)
  • Evaluation of Health Outcomes (920204)
  • Injury Control (920409)
  • Human Pharmaceutical Products (860899)
  • Skin and Related Disorders (920117)
  • Social Structure and Health (920413)

Publications

Total publications

221

Journal Article

(182 outputs)
YearCitationAltmetrics
2017Bostock ECS, Kirkby KC, Taylor BVM, 'The Current Status of the Ketogenic Diet in Psychiatry', Frontiers in Psychology, 8 Article 43. ISSN 1664-1078 (2017) [Refereed Article]

DOI: 10.3389/fpsyt.2017.00043 [eCite] [Details]

Co-authors: Bostock ECS; Kirkby KC

Tweet

2017Bukhari W, Prain KM, Waters P, Woodhall M, O'Gorman CM, et al., 'Incidence and prevalence of NMOSD in Australia and New Zealand', Journal of Neurology, Neurosurgery and Psychiatry, (May) pp. 1-7. ISSN 0022-3050 (2017) [Refereed Article]

DOI: 10.1136/jnnp-2016-314839 [eCite] [Details]

Co-authors: Stankovich J

Tweet

2017Lim CK, Bilgin A, Lovejoy DB, Tan V, Bustamante S, et al., 'Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression', Scientific Reports, 7 Article 41473. ISSN 2045-2322 (2017) [Refereed Article]

DOI: 10.1038/srep41473 [eCite] [Details]

Citations: Scopus - 3

Tweet

2017Stewart T, Spelman T, Havrdova E, Horakova D, Trojano M, et al., 'Contribution of different relapse phenotypes to disability in multiple sclerosis', Multiple Sclerosis Journal, 23, (2) pp. 266-276. ISSN 1352-4585 (2017) [Refereed Article]

DOI: 10.1177/1352458516643392 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Tweet

2017Tettey P, Simpson S, Taylor B, Ponsonby A-L, Lucas RM, et al., 'An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event', Journal of Neurology, Neurosurgery and Psychiatry pp. 1-7. ISSN 0022-3050 (2017) [Refereed Article]

DOI: 10.1136/jnnp-2016-315037 [eCite] [Details]

Citations: Scopus - 1

Co-authors: Tettey P; Simpson S; van der Mei IAF

Tweet

2017Claflin SB, van der Mei IAF, Taylor BV, 'Complementary and alternative treatments of multiple sclerosis: a review of the evidence from 2001 to 2016', Journal of Neurology, Neurosurgery and Psychiatry pp. 1-8. ISSN 0022-3050 (2017) [Refereed Article]

DOI: 10.1136/jnnp-2016-314490 [eCite] [Details]

Co-authors: Claflin SB; van der Mei IAF

Tweet

2016Alla S, Pearson JF, Taylor BV, Miller DH, Clarke G, et al., 'Disability profile of multiple sclerosis in New Zealand', Journal of Clinical Neuroscience, 28 pp. 97-101. ISSN 0967-5868 (2016) [Refereed Article]

DOI: 10.1016/j.jocn.2015.09.020 [eCite] [Details]

Tweet

2016George MF, Briggs FBS, Shao X, Gianfrancesco MA, Kockum I, et al., 'Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies', Neurology: Genetics, 2, (4) Article e87. ISSN 2376-7839 (2016) [Refereed Article]

DOI: 10.1212/NXG.0000000000000087 [eCite] [Details]

Co-authors: van der Mei I; Zhou Y

Tweet

2016Mahurkar S, Moldovan M, Suppiah V, Sorosina M, Clarelli F, et al., 'Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study', Pharmacogenomics Journal pp. 1-7. ISSN 1470-269X (2016) [Refereed Article]

DOI: 10.1038/tpj.2016.20 [eCite] [Details]

Tweet

2016Odenthal C, Simpson Jr S, Oughton J, van der Mei I, Rose S, et al., 'Midsagittal corpus callosum area and conversion to multiple sclerosis after clinically isolated syndrome: A multicentre Australian cohort study', Journal of Medical Imaging and Radiation Oncology pp. 1-8. ISSN 1754-9477 (2016) [Refereed Article]

DOI: 10.1111/1754-9485.12570 [eCite] [Details]

Co-authors: Simpson Jr S; van der Mei I

Tweet

2016Pan G, Simpson Jr S, van der Mei I, Charlesworth JC, Lucas R, et al., 'Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study', Journal of Neurology, Neurosurgery and Psychiatry, 87, (11) pp. 1204-1211. ISSN 0022-3050 (2016) [Refereed Article]

DOI: 10.1136/jnnp-2016-313722 [eCite] [Details]

Citations: Scopus - 1

Co-authors: Simpson Jr S; van der Mei I; Charlesworth JC; Zhou Y; Wu F

Tweet

2016Pearson JF, Alla S, Clarke G, Mason DF, Anderson T, et al., 'Multiple Sclerosis impact on employment and income in New Zealand', Acta Neurologica Scandinavica pp. 1-10. ISSN 0001-6314 (2016) [Refereed Article]

DOI: 10.1111/ane.12714 [eCite] [Details]

Tweet

2016Saul A, Ponsonby A-L, Lucas RM, Taylor BV, Simpson Jr S, et al., 'Stressful life events and the risk of initial central nervous system demyelination', Multiple Sclerosis Journal pp. 1-8. ISSN 1352-4585 (2016) [Refereed Article]

DOI: 10.1177/1352458516667566 [eCite] [Details]

Co-authors: Saul A; Simpson Jr S; van der Mei IAF

Tweet

2016Siejka D, Taylor B, Ponsonby A-L, Dwyer T, van der Mei I, 'Association between exposure to farm animals and pets and risk of Multiple Sclerosis', Multiple Sclerosis and Related Disorders, 10 pp. 53-56. ISSN 2211-0348 (2016) [Refereed Article]

DOI: 10.1016/j.msard.2016.08.015 [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Co-authors: Siejka D; van der Mei I

Tweet

2016Simpson JR S, Stewart N, van der Mei I, Blizzard L, Taylor BV, 'Synergetic and antagonistic effects of combined calcitriol and interferon-β treatment on cytokine production by stimulated PBMCs', Journal of Neuroimmunology, 297 pp. 148-155. ISSN 0165-5728 (2016) [Refereed Article]

DOI: 10.1016/j.jneuroim.2016.05.020 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: Simpson JR S; Stewart N; van der Mei I; Blizzard L

Tweet

2016Simpson S, Tan H, Otahal P, Taylor B, Ponsonby AL, et al., 'Anxiety, depression and fatigue at 5-year review following CNS demyelination', Acta Neurologica Scandinavica, 134, (6) pp. 403-413. ISSN 0001-6314 (2016) [Refereed Article]

DOI: 10.1111/ane.12554 [eCite] [Details]

Citations: Scopus - 5Web of Science - 4

Co-authors: Simpson S; Tan H; Otahal P; Blizzard L; van der Mei I

Tweet

2016Tang Z, Fang Z, Huang W, Liu Z, Chen Y, et al., 'Non-Obese Diabetes and Its Associated Factors in an Underdeveloped Area of South China, Guangxi', International Journal of Environmental Research and Public Health, 13, (10) Article 976. ISSN 1660-4601 (2016) [Refereed Article]

DOI: 10.3390/ijerph13100976 [eCite] [Details]

Co-authors: Simpson Jr S

Tweet

2016Tao C, Simpson Jr S, van der Mei I, Blizzard L, Havrdova E, et al., 'Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 87, (12) pp. 1343-1349. ISSN 0022-3050 (2016) [Refereed Article]

DOI: 10.1136/jnnp-2016-314013 [eCite] [Details]

Citations: Scopus - 4Web of Science - 2

Co-authors: Simpson Jr S; van der Mei I; Blizzard L

Tweet

2016Tettey P, Siejka D, Simpson Jr S, Taylor B, Blizzard L, et al., 'Frequency of comorbidities and their association with clinical disability and relapse in Multiple Sclerosis', Neuroepidemiology, 46, (2) pp. 106-113. ISSN 0251-5350 (2016) [Refereed Article]

DOI: 10.1159/000442203 [eCite] [Details]

Citations: Scopus - 3Web of Science - 3

Co-authors: Tettey P; Siejka D; Simpson Jr S; Blizzard L; van der Mei I

Tweet

2016Van Dijk PA, Kirk-Brown AK, Taylor B, van der Mei I, 'Closing the gap: Longitudinal changes in employment for Australians with multiple sclerosis', Multiple Sclerosis Journal, (November) pp. 1-9. ISSN 1352-4585 (2016) [Refereed Article]

DOI: 10.1177/1352458516678934 [eCite] [Details]

Co-authors: van der Mei I

Tweet

2016Zhou Y, Zhu G, Charlesworth JC, Simpson Jr S, Rubicz R, et al., 'Genetic loci for Epstein-Barr virus nuclear antigen-1 are associated with risk of multiple sclerosis', Multiple Sclerosis Journal, 22, (13) pp. 1655-1664. ISSN 1352-4585 (2016) [Refereed Article]

DOI: 10.1177/1352458515626598 [eCite] [Details]

Citations: Scopus - 4

Co-authors: Zhou Y; Charlesworth JC; Simpson Jr S; Wu F; van der Mei I

Tweet

2016Ahmad H, Taylor BV, van der Mei I, Colman S, O'Leary BA, et al., 'The impact of multiple sclerosis severity on health state utility values: Evidence from Australia', Multiple Sclerosis Journal, (September) pp. 1-10. ISSN 1352-4585 (2016) [Refereed Article]

DOI: 10.1177/1352458516672014 [eCite] [Details]

Co-authors: Ahmad H; van der Mei I; Breslin M; Palmer AJ

Tweet

2016Landowski LM, Dyck PJB, Engelstad J, Taylor BV, 'Axonopathy in peripheral neuropathies: Mechanisms and therapeutic approaches for regeneration', Journal of Chemical Neuroanatomy, 76, (Pt A) pp. 19-27. ISSN 0891-0618 (2016) [Refereed Article]

DOI: 10.1016/j.jchemneu.2016.04.006 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: Landowski LM

Tweet

2015Simpson JR S, Taylor BV, van der Mei I, 'The role of epidemiology in MS research: Past successes, current challenges and future potential', Multiple Sclerosis Journal, 21, (8) pp. 969-977. ISSN 1352-4585 (2015) [Refereed Article]

DOI: 10.1177/1352458515574896 [eCite] [Details]

Citations: Scopus - 2Web of Science - 8

Co-authors: Simpson JR S; van der Mei I

Tweet

2015Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, et al., 'A new era in the treatment of multiple sclerosis', Medical Journal of Australia, 203, (3) pp. 139-141. ISSN 0025-729X (2015) [Refereed Article]

DOI: 10.5694/mja14.01218 [eCite] [Details]

Citations: Scopus - 2Web of Science - 1

Tweet

2015Field J, Shahijanian F, Schibeci S, Johnson L, Gresle M, et al., 'The MS risk allele of CD40 is associated with reduced cell-membrane bound expression in antigen presenting cells: implications for gene function', PLoS One, 10, (6) Article e0127080. ISSN 1932-6203 (2015) [Refereed Article]

DOI: 10.1371/journal.pone.0127080 [eCite] [Details]

Citations: Scopus - 5Web of Science - 3

Co-authors: Charlesworth JC

Tweet

2015Goris A, Pauwels I, Gustavsen MW, van Son B, Hilven K, et al., 'Genetic variants are major determinants of CSF antibody levels in multiple sclerosis', Brain, 138, (3) pp. 632-643. ISSN 0006-8950 (2015) [Refereed Article]

DOI: 10.1093/brain/awu405 [eCite] [Details]

Citations: Scopus - 14Web of Science - 10

Tweet

2015Gu BJ, Field J, Dutertre S, Ou A, Kilpatrick TJ, et al., 'A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis', Human Molecular Genetics, 24, (19) pp. 5644-5654. ISSN 0964-6906 (2015) [Refereed Article]

DOI: 10.1093/hmg/ddv278 [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Co-authors: Stankovich J

Tweet

2015Hoare S, Lithander F, van der Mei I, Ponsonby A-L, Lucas R, et al., 'Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: Results from the Ausimmune Study', Multiple Sclerosis, 22, (7) pp. 884-892. ISSN 1352-4585 (2015) [Refereed Article]

DOI: 10.1177/1352458515604380 [eCite] [Details]

Citations: Scopus - 3Web of Science - 3

Co-authors: van der Mei I

Tweet

2015Landowski LM, Pavez M, Brown LS, Gasperini R, Taylor BV, et al., 'Low-density lipoprotein receptor-related proteins in a novel mechanism of axon guidance and peripheral nerve regeneration', Journal of Biological Chemistry, 291, (3) pp. 1092-1102.. ISSN 1083-351X (2015) [Refereed Article]

DOI: 10.1074/jbc.M115.668996 [eCite] [Details]

Citations: Scopus - 5Web of Science - 3

Co-authors: Landowski LM; Pavez M; Brown LS; Gasperini R; West AK; Foa L

Tweet

2015Lin R, Taylor BV, Charlesworth J, van der Mei I, Blizzard L, et al., 'Modulating effects of WT1 on interferon-β-vitamin D association in MS', Acta Neurologica Scandinavica, 131, (4) pp. 231-239. ISSN 0001-6314 (2015) [Refereed Article]

DOI: 10.1111/ane.12315 [eCite] [Details]

Citations: Scopus - 6Web of Science - 7

Co-authors: Charlesworth J; van der Mei I; Blizzard L; Stewart N; Pittas F; Simpson JR S

Tweet

2015Mathey EK, Park SB, Hughes RA, Pollard JD, Armati PJ, et al., 'Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype', Journal of Neurology, Neurosurgery and Psychiatry, 86 pp. 973-985. ISSN 0022-3050 (2015) [Refereed Article]

DOI: 10.1136/jnnp-2014-309697 [eCite] [Details]

Citations: Scopus - 59

Tweet

2015Moutsianas L, Jostins L, Beecham AH, Dilthey AT, Xifara DK, et al., 'Class II HLA interactions modulate genetic risk for multiple sclerosis', Nature Genetics, 47, (10) pp. 1107-1113. ISSN 1061-4036 (2015) [Refereed Article]

DOI: 10.1038/ng.3395 [eCite] [Details]

Citations: Scopus - 25Web of Science - 27

Tweet

2015Bostock ECS, Kirkby KC, Garry MI, Taylor BVM, 'Comparison of precipitating factors for mania and partial seizures: Indicative of shared pathophysiology?', Journal of Affective Disorders, 183 pp. 57-67. ISSN 0165-0327 (2015) [Refereed Article]

DOI: 10.1016/j.jad.2015.04.057 [eCite] [Details]

Citations: Scopus - 5

Co-authors: Bostock ECS; Kirkby KC; Garry MI

Tweet

2015Simpson Jr S, Mina S, Morris H, Mahendran S, Taylor B, et al., 'The epidemiology of multiple sclerosis in the Isle of Man: 2006-2011', Acta Neurologica Scandinavica, 132, (6) pp. 381-388. ISSN 0001-6314 (2015) [Refereed Article]

DOI: 10.1111/ane.12405 [eCite] [Details]

Citations: Scopus - 2Web of Science - 1

Co-authors: Simpson Jr S

Tweet

2015Simpson Jr S, Stewart N, van der Mei I, Otahal P, Charlesworth J, et al., 'Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: Results from a prospective cohort study', Journal of Neurology, Neurosurgery and Psychiatry, 86 pp. 200-207. ISSN 0022-3050 (2015) [Refereed Article]

DOI: 10.1136/jnnp-2013-307336 [eCite] [Details]

Citations: Scopus - 7

Co-authors: Simpson Jr S; Stewart N; van der Mei I; Otahal P; Charlesworth J; Blizzard L; Pittas F

Tweet

2015Simpson Jr S, van der Mei I, Stewart N, Blizzard L, Tettey P, et al., 'Weekly cholecalciferol supplementation results in significant reductions in infection risk among the vitamin D deficient: results from the CIPRIS pilot RCT', BMC Nutrition, 1 Article 7. ISSN 2055-0928 (2015) [Refereed Article]

DOI: 10.1186/2055-0928-1-7 [eCite] [Details]

Co-authors: Simpson Jr S; van der Mei I; Stewart N; Blizzard L; Tettey P

Tweet

2015Taylor B, Moses H, Paul F, Suarez G, Rametta M, 'Treatment of Multiple Sclerosis - Relationship between Vitamin D and Interferon β-1b', European Neurological Review, 10, (2) pp. 124-130. ISSN 1758-3837 (2015) [Refereed Article]

DOI: 10.17925/ENR.2015.10.02.124 [eCite] [Details]

Tweet

2015Tettey P, Simpson Jr S, Taylor BV, van der Mei IAF, 'The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology', Journal of the Neurological Sciences, 348, (1-2) pp. 126-131. ISSN 0022-510X (2015) [Refereed Article]

DOI: 10.1016/j.jns.2014.11.019 [eCite] [Details]

Citations: Scopus - 6Web of Science - 6

Co-authors: Tettey P; Simpson Jr S; van der Mei IAF

Tweet

2015Zhou Y, Taylor B, van der Mei I, Stewart N, Charlesworth J, et al., 'Genetic variation in PBMC-produced IFN-γ and TNF-α associations with relapse in multiple sclerosis', Journal of The Neurological Sciences, 349, (1-2) pp. 40-44. ISSN 0022-510X (2015) [Refereed Article]

DOI: 10.1016/j.jns.2014.12.022 [eCite] [Details]

Co-authors: Zhou Y; van der Mei I; Stewart N; Charlesworth J; Blizzard L; Pittas F; Simpson Jr S

Tweet

2015van der Mei IAF, Lucas RM, Taylor BV, Valery PC, Dwyer T, et al., 'Population attributable fractions and joint effects of key risk factors for multiple sclerosis', Multiple Sclerosis Journal pp. 1-9. ISSN 1352-4585 (2015) [Refereed Article]

DOI: 10.1177/1352458515594040 [eCite] [Details]

Citations: Scopus - 7

Co-authors: van der Mei IAF; Otahal P

Tweet

2015Black LJ, Anderson D, Clarke MW, Ponsonby A-L, Lucas RM, et al., 'Analytical bias in the measurement of serum 25-hydroxyvitamin D concentrations impairs assessment of vitamin D Status in clinical and research settings', PL o S One, 10, (8) Article e0135478. ISSN 1932-6203 (2015) [Refereed Article]

DOI: 10.1371/journal.pone.0135478 [eCite] [Details]

Citations: Scopus - 7Web of Science - 7

Co-authors: van der Mei I

Tweet

2015Dyck PJ, Taylor BV, Davies JL, Mauermann ML, Litchy WJ, et al., 'Office immunotherapy in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy', Muscle and Nerve, 52, (4) pp. 488-497. ISSN 0148-639X (2015) [Refereed Article]

DOI: 10.1002/mus.24707 [eCite] [Details]

Citations: Scopus - 3Web of Science - 2

Tweet

2014Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, et al., 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy', Journal of Clinical Neuroscience, 21, (11) pp. 1847-1856. ISSN 0967-5868 (2014) [Refereed Article]

DOI: 10.1016/j.jocn.2014.01.018 [eCite] [Details]

Citations: Scopus - 6Web of Science - 2

Tweet

2014Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, et al., 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations', Journal of Clinical Neuroscience, 21, (11) pp. 1857-1865. ISSN 0967-5868 (2014) [Refereed Article]

DOI: 10.1016/j.jocn.2014.01.017 [eCite] [Details]

Citations: Scopus - 6Web of Science - 2

Tweet

2014Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, et al., 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies', Journal of Clinical Neuroscience, 21, (11) pp. 1835-1846. ISSN 0967-5868 (2014) [Refereed Article]

DOI: 10.1016/j.jocn.2014.01.016 [eCite] [Details]

Citations: Scopus - 3Web of Science - 1

Tweet

2014Goris A, van Setten J, Diekstra F, Ripke S, Patsopoulos NA, et al., 'No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis', Human Molecular Genetics, 23, (7) pp. 1916-1922. ISSN 0964-6906 (2014) [Refereed Article]

DOI: 10.1093/hmg/ddt574 [eCite] [Details]

Citations: Scopus - 6Web of Science - 5

Co-authors: Foote SJ; Stankovich J

Tweet

2014Gresle MM, Liu Y, Dagley LF, Haartsen J, Pearson F, et al., 'Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients', Journal of Neurology, Neurosurgery and Psychiatry, 85, (11) pp. 1209-1213. ISSN 0022-3050 (2014) [Refereed Article]

DOI: 10.1136/jnnp-2013-306789 [eCite] [Details]

Citations: Scopus - 9Web of Science - 10

Tweet

2014Knippenberg S, Damoiseaux J, Bol Y, Hupperts R, Taylor BV, et al., 'Higher levels of reported sun exposure, and not vitamin D status, are associated with less depressive symptoms and fatigue in multiple sclerosis', Acta Neurologica Scandinavica, 129, (2) pp. 123-131. ISSN 0001-6314 (2014) [Refereed Article]

DOI: 10.1111/ane.12155 [eCite] [Details]

Citations: Scopus - 10Web of Science - 7

Co-authors: Simpson S; van der Mei IAF

Tweet

2014Lin R, Taylor BV, Simpson Jr S, Charlesworth J, Ponsonby A-L, et al., 'Association between multiple sclerosis risk-associated SNPs and relapse and disability - a prospective cohort study', Multiple Sclerosis, 20, (3) pp. 313-321. ISSN 1352-4585 (2014) [Refereed Article]

DOI: 10.1177/1352458513496882 [eCite] [Details]

Citations: Scopus - 12Web of Science - 8

Co-authors: Simpson Jr S; Charlesworth J; Pittas F; van der Mei I

Tweet

2014Lin R, Taylor BV, Simpson Jr S, Charlesworth J, Ponsonby A-L, et al., 'Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 85, (4) pp. 399-404. ISSN 0022-3050 (2014) [Refereed Article]

DOI: 10.1136/jnnp-2013-305245 [eCite] [Details]

Citations: Scopus - 14Web of Science - 10

Co-authors: Simpson Jr S; Charlesworth J; Pittas F; van der Mei IAF

Tweet

2014Pearson JF, Alla S, Clarke G, Taylor BV, Miller DH, et al., 'Multiple sclerosis in New Zealand Māori', Multiple Sclerosis Journal, 20, (14) pp. 1892-1895. ISSN 1477-0970 (2014) [Refereed Article]

DOI: 10.1177/1352458514535130 [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Tweet

2014Shahijanian F, Parnell GP, McKay FC, Gatt PN, Shojoei M, et al., 'The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells', Human Molecular Genetics, 23, (6) pp. 1425-1434. ISSN 1460-2083 (2014) [Refereed Article]

DOI: 10.1093/hmg/ddt529 [eCite] [Details]

Citations: Scopus - 18Web of Science - 16

Co-authors: Charlesworth J

Tweet

2014Simpson JR S, Taylor BV, 'The Scandinavian paradox revisited: Editorial comment on Berg-Hansen et al. 'High prevalence and no latitude gradient of multiple sclerosis in Norway'', Multiple Sclerosis Journal, 20, (13) pp. 1675-1677. ISSN 1352-4585 (2014) [Contribution to Refereed Journal]

DOI: 10.1177/1352458514535474 [eCite] [Details]

Citations: Scopus - 2

Co-authors: Simpson JR S

Tweet

2014Simpson Jr S, Taylor B, Burrows J, Burrows S, Dwyer DE, et al., 'EBV & HHV6 reactivation is infrequent and not associated with MS clinical course', Acta Neurologica Scandinavica, 130, (5) pp. 328-337. ISSN 0001-6314 (2014) [Refereed Article]

DOI: 10.1111/ane.12268 [eCite] [Details]

Citations: Scopus - 10Web of Science - 7

Co-authors: Simpson Jr S; Blizzard L; Pittas F; van der Mei I

Tweet

2014Tettey P, Simpson Jr S, Taylor B, Blizzard L, Ponsonby A-L, et al., 'An adverse lipid profile is associated with disability and progression in disability, in people with MS', Multiple Sclerosis Journal, 20, (13) pp. 1737-1744. ISSN 1477-0970 (2014) [Refereed Article]

DOI: 10.1177/1352458514533162 [eCite] [Details]

Citations: Scopus - 25Web of Science - 20

Co-authors: Tettey P; Simpson Jr S; Blizzard L; van der Mei I

Tweet

2014Tettey P, Simpson Jr S, Taylor B, Blizzard L, Ponsonby A-L, et al., 'Adverse lipid profile is not associated with relapse risk in MS: Results from an observational cohort study', Journal of the Neurological Sciences, 340, (1-2) pp. 230-232. ISSN 1878-5883 (2014) [Refereed Article]

DOI: 10.1016/j.jns.2014.02.038 [eCite] [Details]

Citations: Scopus - 13Web of Science - 13

Co-authors: Tettey P; Simpson Jr S; Blizzard L; van der Mei I

Tweet

2014Tettey P, Simpson Jr S, Taylor BV, van der Mei IAF, 'Vascular comorbidities in the onset and progression of multiple sclerosis', Journal of The Neurological Sciences, 347, (1-2) pp. 23-33. ISSN 0022-510X (2014) [Refereed Article]

DOI: 10.1016/j.jns.2014.10.020 [eCite] [Details]

Citations: Scopus - 21Web of Science - 19

Co-authors: Tettey P; Simpson Jr S; van der Mei IAF

Tweet

2014Zhou Y, Simpson Jr S, Holloway AF, Charlesworth J, van der Mei I, et al., 'The potential role of epigenetic modifications in the heritability of multiple sclerosis', Multiple Sclerosis Journal, 20, (2) pp. 135-140. ISSN 1352-4585 (2014) [Refereed Article]

DOI: 10.1177/1352458514520911 [eCite] [Details]

Citations: Scopus - 14Web of Science - 11

Co-authors: Zhou Y; Simpson Jr S; Holloway AF; Charlesworth J; van der Mei I

Tweet

2014van der Mei IAF, Otahal P, Simpson Jr S, Taylor B, Winzenberg T, 'Meta-analyses to investigate gene-environment interactions in neuroepidemiology', Neuroepidemiology, 42, (1) pp. 39-49. ISSN 0251-5350 (2014) [Refereed Article]

DOI: 10.1159/000355439 [eCite] [Details]

Citations: Scopus - 3Web of Science - 2

Co-authors: van der Mei IAF; Otahal P; Simpson Jr S; Winzenberg T

Tweet

2014Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, et al., 'Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity', Neurology, 83, (11) pp. 1022-1024. ISSN 0028-3878 (2014) [Contribution to Refereed Journal]

DOI: 10.1212/WNL.0000000000000768 [eCite] [Details]

Citations: Scopus - 63

Tweet

2013Baranzini SE, Khankhanian P, Patsopoulos NA, Li M, Stankovich J, et al., 'Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls', American Journal of Human Genetics: A Record of Research, Review and Bibliographic Material Relating to Heredity in Man, 92, (6) pp. 854-865. ISSN 0002-9297 (2013) [Refereed Article]

DOI: 10.1016/j.ajhg.2013.04.019 [eCite] [Details]

Citations: Scopus - 71Web of Science - 54

Co-authors: Stankovich J

Tweet

2013Buck D, Albrecht E, Aslam M, Goris A, Hauenstein N, et al., 'Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis', Annals of Neurology, 73, (1) pp. 86-94. ISSN 0364-5134 (2013) [Refereed Article]

DOI: 10.1002/ana.23749 [eCite] [Details]

Citations: Scopus - 16Web of Science - 10

Co-authors: Stankovich J

Tweet

2013Cortes A, Field J, Glazov EA, Hadler J, Stankovich J, et al., 'Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes', Human Molecular Genetics, 22, (11) pp. 2283-2292. ISSN 0964-6906 (2013) [Refereed Article]

DOI: 10.1093/hmg/ddt062 [eCite] [Details]

Citations: Scopus - 12Web of Science - 10

Co-authors: Stankovich J; Charlesworth J

Tweet

2013Disanto G, Hall C, Lucas R, Ponsonby A-L, Berlanga-Taylor AJ, et al., 'Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis', Multiple Sclerosis, 19, (10) pp. 1355-1358. ISSN 1352-4585 (2013) [Refereed Article]

DOI: 10.1177/1352458513477231 [eCite] [Details]

Citations: Scopus - 7Web of Science - 3

Co-authors: van der Mei I

Tweet

2013Guo S, Lucas RM, Ponsonby A-L, Chapman C, Coulthard A, et al., 'A novel approach for prediction of vitamin D status using support vector regression', PLoS One, 8, (11) Article e79970. ISSN 1932-6203 (2013) [Refereed Article]

DOI: 10.1371/journal.pone.0079970 [eCite] [Details]

Citations: Scopus - 2Web of Science - 1

Co-authors: van der Mei I

Tweet

2013Hewer S, Lucas R, van der Mei I, Taylor BV, 'Vitamin D and multiple sclerosis', Journal of Clinical Neuroscience, 20, (5) pp. 634-641. ISSN 0967-5868 (2013) [Refereed Article]

DOI: 10.1016/j.jocn.2012.10.005 [eCite] [Details]

Citations: Scopus - 25Web of Science - 21

Co-authors: van der Mei I

Tweet

2013Hughes A-M, Lucas RM, McMichael AJ, Dwyer T, Pender MP, et al., 'Early-life hygiene-related factors affect risk of central nervous system demyelination and asthma differentially', Clinical and Experimental Immunology, 172, (3) pp. 466-474. ISSN 0009-9104 (2013) [Refereed Article]

DOI: 10.1111/cei.12077 [eCite] [Details]

Citations: Scopus - 8Web of Science - 6

Co-authors: van der Mei I

Tweet

2013Lee SH, Harold D, Nyholt DR, Scott RJ, Lechner-Scott J, et al., 'Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis', Human Molecular Genetics, 22, (4) pp. 832-841. ISSN 0964-6906 (2013) [Refereed Article]

DOI: 10.1093/hmg/dds491 [eCite] [Details]

Citations: Scopus - 77Web of Science - 76

Co-authors: Foote SJ; Stankovich J

Tweet

2013Lin R, Charlesworth J, Stankovich J, Perreau VM, Brown MA, et al., 'Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis', PLoS ONE, 8, (3) Article e56379. ISSN 1932-6203 (2013) [Refereed Article]

DOI: 10.1371/journal.pone.0056379 [eCite] [Details]

Citations: Scopus - 11Web of Science - 8

Co-authors: Charlesworth J; Stankovich J

Tweet

2013Lucas RM, Ponsonby AL, Dear K, Valery PC, Taylor B, et al., 'Vitamin D status: Multifactorial contribution of environment, genes and other factors in healthy Australian adults across a latitude gradient', Journal of Steroid Biochemistry and Molecular Biology, 136, (13) pp. 300-308. ISSN 0960-0760 (2013) [Refereed Article]

DOI: 10.1016/j.jsbmb.2013.01.011 [eCite] [Details]

Citations: Scopus - 37Web of Science - 35

Co-authors: van der Mei I; Stankovich J

Tweet

2013Lucas RM, Taylor BV, 'Challenges in exposure and outcome definition in neuroepidemiology: the case of vitamin D and multiple sclerosis', Australasian Epidemiologist, 20, (1) pp. 4-8. ISSN 1327-8835 (2013) [Non Refereed Article]

[eCite] [Details]

2013Beechham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, et al., 'Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis', Nature Genetics, 45, (11) pp. 1353-1360. ISSN 1061-4036 (2013) [Refereed Article]

DOI: 10.1038/ng.2770 [eCite] [Details]

Citations: Scopus - 424Web of Science - 231

Tweet

2013Mechelli R, Umeton R, Policano C, Annibali V, Coarelli G, et al., 'A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis', PLoS One, 8, (5) Article e63300. ISSN 1932-6203 (2013) [Refereed Article]

DOI: 10.1371/journal.pone.0063300 [eCite] [Details]

Citations: Scopus - 18Web of Science - 16

Co-authors: Foote S; Stankovich J

Tweet

2013Palmer AJ, Colman S, O'Leary B, Taylor BV, Simmons RD, 'The economic impact of multiple sclerosis in Australia in 2010', Multiple Sclerosis, 19, (12) pp. 1640-1646. ISSN 1352-4585 (2013) [Refereed Article]

DOI: 10.1177/1352458513488230 [eCite] [Details]

Citations: Scopus - 16Web of Science - 10

Co-authors: Palmer AJ

Tweet

2013Palmer AJ, Hitchens PL, Simpson Jr S, O'Leary B, Colman S, et al., 'A novel method for calculating prevalence of multiple sclerosis in Australia', Multiple Sclerosis, 19, (13) pp. 1704-1711. ISSN 1352-4585 (2013) [Refereed Article]

DOI: 10.1177/1352458513479841 [eCite] [Details]

Citations: Scopus - 6Web of Science - 5

Co-authors: Palmer AJ; Hitchens PL; Simpson Jr S

Tweet

2013Patsopoulos NA, Barcellos LF, Hintzen RQ, Schaefer C, van Duijn CM, et al., 'Fine-mapping the genetic association of the major histocompatibility complex in Multiple Sclerosis: HLA and non-HLA effects', PLoS Genetics, 9, (11) Article e1003926. ISSN 1553-7404 (2013) [Refereed Article]

DOI: 10.1371/journal.pgen.1003926 [eCite] [Details]

Citations: Scopus - 70Web of Science - 58

Co-authors: Foote SJ; Stankovich J

Tweet

2013Ponsonby A-L, Lucas RM, Dear K, van der Mei I, Taylor B, et al., 'The physical anthropometry, lifestyle habits and blood pressure of people presenting with a first clinical demyelinating event compared to controls: the Ausimmune study', Multiple Sclerosis Journal, 19, (13) pp. 1717-1725. ISSN 1352-4585 (2013) [Refereed Article]

DOI: 10.1177/1352458513483887 [eCite] [Details]

Citations: Scopus - 5Web of Science - 1

Co-authors: van der Mei I

Tweet

2013Simpson Jr S, Blizzard L, Taylor B, Tettey P, van der Mei I, 'Is your association real or just reverse causality? Some examples from analyses of multiple sclerosis clinical course and tools to assess it', Australasian Epidemiologist, 20.1 pp. 34-37. ISSN 1327-8835 (2013) [Non Refereed Article]

[eCite] [Details]

Co-authors: Simpson Jr S; Blizzard L; Tettey P; van der Mei I

2013Taylor BV, 'Time to onset of secondary progression as an outcome in MS trials: a new paradigm?', Journal of Neurology, Neurosurgery and Psychiatry pp. 1. ISSN 0022-3050 (2013) [Letter or Note in Journal]

DOI: 10.1136/jnnp-2012-304611 [eCite] [Details]

Citations: Scopus - 2

Tweet

2013Taylor BV, 'Sunshine and multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 84, (10) pp. 1066. ISSN 0022-3050 (2013) [Letter or Note in Journal]

DOI: 10.1136/jnnp-2012-304825 [eCite] [Details]

Citations: Scopus - 1

Tweet

2013Taylor BV, Palmer A, Simpson Jr S, Lucas R, Simmons RD, et al., 'Assessing possible selection bias in a national voluntary MS longitudinal study in Australia', Multiple Sclerosis, 19, (12) pp. 1627-1631. ISSN 1352-4585 (2013) [Refereed Article]

DOI: 10.1177/1352458513481511 [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Co-authors: Palmer A; Simpson Jr S

Tweet

2013Toi CS, Lay M-L J, Lucas R, Chew CB, Taylor J, et al., 'Varicella zoster virus quantitation in blood from symptomatic and asymptomatic individuals', Journal of Medical Virology, 85, (8) pp. 1491-1497. ISSN 0146-6615 (2013) [Refereed Article]

DOI: 10.1002/jmv.23605 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: van der Mei I

Tweet

2013Valery PC, Lucas RM, Williams DB, Pender MP, Chapman C, et al., 'Occupational Exposure and Risk of Central Nervous System Demyelination', American Journal of Epidemiology, 177, (9) pp. 954-961. ISSN 0002-9262 (2013) [Refereed Article]

DOI: 10.1093/aje/kws361 [eCite] [Details]

Citations: Scopus - 8Web of Science - 5

Co-authors: van der Mei I

Tweet

2013Lucas RM, Valery P, van der Mei I, Dwyer T, Pender MP, et al., 'Sun exposure over a lifetime in Australian adults from latitudinally diverse regions', Photochemistry and Photobiology, 89, (3) pp. 737-744. ISSN 0031-8655 (2013) [Refereed Article]

DOI: 10.1111/php.12044 [eCite] [Details]

Citations: Scopus - 13Web of Science - 12

Co-authors: van der Mei I

Tweet

2012Curley M, Josey L, Lucas R, Dear K, Taylor BV, et al., 'Adherence to MRI protocol consensus guidelines in multiple sclerosis: An Australian multi-centre study', Journal of Medical Imaging and Radiation Oncology, 56, (6) pp. 594-598. ISSN 1754-9477 (2012) [Refereed Article]

DOI: 10.1111/1754-9485.12000 [eCite] [Details]

Citations: Scopus - 2Web of Science - 3

Co-authors: van der Mei I

Tweet

2012D'Souza WJ, Quinn SJ, Fryer JL, Taylor BV, Ficker DM, et al., 'The prevalence and demographic distribution of treated epilepsy: a community-based study in Tasmania, Australia', Acta Neurologica Scandinavica, 125, (2) pp. 96-104. ISSN 0001-6314 (2012) [Refereed Article]

DOI: 10.1111/j.1600-0404.2011.01499.x [eCite] [Details]

Citations: Scopus - 9Web of Science - 8

Co-authors: D'Souza WJ; Quinn SJ; Fryer JL

Tweet

2012Josey L, Curley M, Jafari Mousavi F, Taylor BV, Lucas R, et al., 'Imaging and diagnostic criteria for Multiple Sclerosis: Are we there yet?', Journal of Medical Imaging and Radiation Oncology, 56, (6) pp. 588-593. ISSN 1754-9477 (2012) [Contribution to Refereed Journal]

DOI: 10.1111/j.1754-9485.2012.02448.x [eCite] [Details]

Citations: Scopus - 1

Tweet

2012Lai JKC, Lucas RM, Banks E, Ponsonby A-L, Chapman C, et al., 'Variability in vitamin D assays impairs clinical assessment of vitamin D status', Internal Medicine Journal, 42, (1) pp. 43-50. ISSN 1444-0903 (2012) [Refereed Article]

DOI: 10.1111/j.1445-5994.2011.02471.x [eCite] [Details]

Citations: Scopus - 78Web of Science - 74

Co-authors: Van der Mei I

Tweet

2012Lill CM, Liu T, Schjeide B-MM, Roehr JT, Akkad DA, et al., 'Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects', Journal of Medical Genetics, 49, (9) pp. 558-562. ISSN 0022-2593 (2012) [Refereed Article]

DOI: 10.1136/jmedgenet-2012-101175 [eCite] [Details]

Citations: Scopus - 14Web of Science - 14

Co-authors: Drysdale K; Foote SJ

Tweet

2012Lucas RM, Taylor BV, 'Epstein-Barr virus infection: a smoking gun for multiple sclerosis?', Neurology, 79, (13) pp. 1310-1311. ISSN 0028-3878 (2012) [Letter or Note in Journal]

DOI: 10.1212/WNL.0b013e31826c1baf [eCite] [Details]

Citations: Scopus - 1

Tweet

2012Ponsonby AL, Lucas RM, van der Mei IA, Dear K, Valery PC, et al., 'Offspring number, pregnancy, and risk of a first clinical demyelinating event: The AusImmune Study', Neurology, 78, (12) pp. 867-874. ISSN 0028-3878 (2012) [Refereed Article]

DOI: 10.1212/WNL.0b013e31824c4648 [eCite] [Details]

Citations: Scopus - 56Web of Science - 42

Co-authors: van der Mei IA

Tweet

2012Richardson AK, Clarke G, Sabel CE, Pearson JF, Mason DF, et al., 'Method for identifying eligible individuals for a prevalence survey in the absence of a disease register or population register', Internal Medicine Journal, 42, (11) pp. 1207-1212. ISSN 1444-0903 (2012) [Refereed Article]

DOI: 10.1111/j.1445-5994.2012.02754.x [eCite] [Details]

Citations: Scopus - 2Web of Science - 1

Tweet

2012Simpson Jr S, Taylor B, Dwyer DE, Taylor J, Blizzard L, et al., 'Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis', Multiple sclerosis journal, 18, (6) pp. 799-806. ISSN 1477-0970 (2012) [Refereed Article]

DOI: 10.1177/1352458511428081 [eCite] [Details]

Citations: Scopus - 18Web of Science - 16

Co-authors: Simpson Jr S; Blizzard L; Pittas F; Van der Mei I

Tweet

2012Simpson Jr S, Taylor B, van der Mei I, 'A profile of the Multiple Sclerosis Longitudinal Study: Evaluating environmental, behavioural and genetic predictors of clinical outcomes in multiple sclerosis', Australasian Epidemiologist, 19, (2) pp. 33-37. ISSN 1327-8835 (2012) [Non Refereed Article]

[eCite] [Details]

Co-authors: Simpson Jr S; van der Mei I

2012Stewart N, Simpson Jr S, van der Mei I, Ponsonby A-L, Blizzard L, et al., 'Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS', Neurology, 79, (3) pp. 254-260. ISSN 0028-3878 (2012) [Refereed Article]

DOI: 10.1212/WNL.0b013e31825fded9 [eCite] [Details]

Citations: Scopus - 50Web of Science - 40

Co-authors: Stewart N; Simpson Jr S; van der Mei I; Blizzard L; Pittas F

Tweet

2012Taylor BV, 'Predicting MS progression: patience is a virtue', Journal of Neurology, Neurosurgery and Psychiatry, 83, (6) pp. 578. ISSN 0022-3050 (2012) [Letter or Note in Journal]

DOI: 10.1136/jnnp-2012-302207 [eCite] [Details]

Tweet

2012Trojano M, Lucchese G, Graziano G, Taylor BV, Simpson JR S, et al., 'Geographical variations in sex ratio trends over time in multiple sclerosis', PLoS ONE, 7, (10) Article e48078. ISSN 1932-6203 (2012) [Refereed Article]

DOI: 10.1371/journal.pone.0048078 [eCite] [Details]

Citations: Scopus - 58Web of Science - 42

Co-authors: Simpson JR S

Tweet

2012Wood B, van der Mei IAF, Ponsonby AL, Pittas F, Quinn S, et al., 'Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis', Multiple Sclerosis, 19, (2) pp. 217-224. ISSN 1352-4585 (2012) [Refereed Article]

DOI: 10.1177/1352458512450351 [eCite] [Details]

Citations: Scopus - 74Web of Science - 58

Co-authors: Wood B; van der Mei IAF; Pittas F

Tweet

2012Yan J, Liu J, Lin CY, Scott RJ, Lechner-Scott J, et al., 'Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis', International Journal of Molecular Sciences, 13, (10) pp. 13667-13679. ISSN 1422-0067 (2012) [Refereed Article]

DOI: 10.3390/ijms131013667 [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Tweet

2011Lucas RM, Hughes AM, Lay MLJ, Ponsonby AL, Dwyer DE, et al., 'Epstein-Barr virus and multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 82, (10) pp. 1142-1148. ISSN 0022-3050 (2011) [Refereed Article]

DOI: 10.1136/jnnp-2011-300174 [eCite] [Details]

Citations: Scopus - 55Web of Science - 43

Tweet

2011Lucas RM, Ponsonby AL, Dear K, Valery P, Pender MP, et al., 'Current and past Epstein-Barr virus infection in risk of initial CNS demyelination', Neurology, 77, (4) pp. 371-379. ISSN 0028-3878 (2011) [Refereed Article]

DOI: 10.1212/WNL.0b013e318227062a [eCite] [Details]

Citations: Scopus - 50Web of Science - 45

Co-authors: van der Mei IAF

Tweet

2011Ma GZM, Stankovich J, Bahlo M, Booth DR, Broadley S, et al., 'Polymorphisms in the Receptor Tyrosine Kinase MERTK Gene Are Associated with Multiple Sclerosis Susceptibility', PL o S One, 6, (2) EJ ISSN 1932-6203 (2011) [Refereed Article]

DOI: 10.1371/journal.pone.0016964 [eCite] [Details]

Citations: Scopus - 17Web of Science - 13

Co-authors: Stankovich J; Foote SJ

Tweet

2011O'Gorman C, Freeman S, Taylor BV, Butzkueven H, Broadley SA, 'Familial recurrence risks for multiple sclerosis in Australia', Journal of Neurology, Neurosurgery and Psychiatry, 82, (12) pp. 1351-1354. ISSN 0022-3050 (2011) [Refereed Article]

DOI: 10.1136/jnnp.2010.233064 [eCite] [Details]

Citations: Scopus - 10Web of Science - 10

Tweet

2011Patsopoulos NA, de Bakker PI, Esposito F, Reischl J, Lehr S, et al., 'Genome-Wide Meta-Analysis Identifies Novel Multiple Sclerosis Susceptibility Loci', Annals of Neurology, 70, (6) pp. 897-912. ISSN 0364-5134 (2011) [Refereed Article]

DOI: 10.1002/ana.22609 [eCite] [Details]

Citations: Scopus - 179Web of Science - 164

Co-authors: Foote SJ; Perera D; Stankovich J

Tweet

2011Ritchie ME, Liu R, Carvalho BS, Bahlo M, Booth DR, et al., 'Comparing genotyping algorithms for Illumina's Infinium whole-genome SNP BeadChips', BMC Bioinformatics, 12, (March) EJ ISSN 1471-2105 (2011) [Refereed Article]

DOI: 10.1186/1471-2105-12-68 [eCite] [Details]

Citations: Scopus - 20Web of Science - 22

Co-authors: Foote SJ; Stankovich J; Dickinson JL; Drysdale K; Guru P; Hoban E; McMorran BJ; Polanowski A; Whittock L; Perera D

Tweet

2011Sawcer S, Hellenthal G, Pirinen M, Spencer CCA, Patsopoulos NA, et al., 'Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis', Nature, 476, (7359) pp. 214-219. ISSN 0028-0836 (2011) [Refereed Article]

DOI: 10.1038/nature10251 [eCite] [Details]

Citations: Scopus - 1215Web of Science - 1088

Co-authors: Foote SJ; Stankovich J

Tweet

2011Simpson Jr S, Blizzard L, Otahal P, Van der Mei I, Taylor B, 'Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis', Journal of Neurology, Neurosurgery and Psychiatry, 82, (10) pp. 1132-1141. ISSN 0022-3050 (2011) [Refereed Article]

DOI: 10.1136/jnnp.2011.240432 [eCite] [Details]

Citations: Scopus - 249Web of Science - 204

Co-authors: Simpson Jr S; Blizzard L; Otahal P; Van der Mei I

Tweet

2011Simpson S, Pittas F, van der Mei I, Blizzard L, Ponsonby AL, et al., 'Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009', Journal of Neurology, Neurosurgery and Psychiatry, 82, (2) pp. 180-187. ISSN 0022-3050 (2011) [Refereed Article]

DOI: 10.1136/jnnp.2010.215186 [eCite] [Details]

Citations: Scopus - 33Web of Science - 24

Co-authors: Simpson S; Pittas F; van der Mei I; Blizzard L

Tweet

2011Taylor BV, 'Ireland: a fine place for multiple sclerosis research', Journal of Neurology, Neurosurgery and Psychiatry, 82, (3) pp. 237. ISSN 0022-3050 (2011) [Non Refereed Article]

DOI: 10.1136/jnnp.2010.234237 [eCite] [Details]

Tweet

2011Van der Walt A, Stankovich J, Bahlo M, Taylor BV, Van der Mei IAF, et al., 'Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition ', Multiple Sclerosis, 17, (3) pp. 344-352. ISSN 1352-4585 (2011) [Refereed Article]

DOI: 10.1177/1352458510389101 [eCite] [Details]

Citations: Scopus - 16Web of Science - 11

Co-authors: Stankovich J; Van der Mei IAF; Foote SJ

Tweet

2011Wang JH, Pappas D, De Jager P, Pelletier D, de Bakker PIW, et al., 'Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data', Genome Medicine, 3, (3) EJ ISSN 1756-994X (2011) [Refereed Article]

DOI: 10.1186/gm217 [eCite] [Details]

Citations: Scopus - 43Web of Science - 38

Co-authors: Foote SJ; Stankovich J

Tweet

2011Lucas RM, Ponsonby AL, Dear K, Valery PC, Pender MP, et al., 'Sun exposure and vitamin D are independent risk factors for CNS demyelination', Neurology, 76, (6) pp. 540-548 . ISSN 0028-3878 (2011) [Refereed Article]

DOI: 10.1212/WNL.0b013e31820af93d [eCite] [Details]

Citations: Scopus - 164Web of Science - 138

Co-authors: van der Mei I

Tweet

2010van der Mei IAF, Ponsonby AL, Taylor BV, Stankovich J, Dickinson JL, et al., 'Human Leukocyte Antigen-DR15, Low Infant Sibling Exposure and Multiple Sclerosis: Gene-Environment Interaction', Annals of Neurology, 67, (2) pp. 261-265. ISSN 0364-5134 (2010) [Refereed Article]

DOI: 10.1002/ana.21849 [eCite] [Details]

Citations: Scopus - 17Web of Science - 13

Co-authors: van der Mei IAF; Ponsonby AL; Stankovich J; Dickinson JL; Foote S; Dwyer T

Tweet

2010Cox MB, Cairns MJ, Gandhi KS, Carroll AP, Moscovis S, et al., 'MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood', P L o S One, 5, (8) EJ ISSN 1932-6203 (2010) [Refereed Article]

DOI: 10.1371/journal.pone.0012132 [eCite] [Details]

Citations: Scopus - 129Web of Science - 107

Co-authors: Foote SJ; Stankovich J

Tweet

2010Gandhi KS, McKay FC, Cox M, Riveros C, Armstrong N, et al., 'The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis ', Human Molecular Genetics, 19, (11) pp. 2134-2143. ISSN 0964-6906 (2010) [Refereed Article]

DOI: 10.1093/hmg/ddq090 [eCite] [Details]

Citations: Scopus - 59Web of Science - 55

Co-authors: Stankovich J; Foote SJ

Tweet

2010Hughes AM, Lucas RM, Ponsonby AL, Chapman C, Coulthard A, et al., 'The role of latitude, ultraviolet radiation exposure and vitamin D in childhood asthma and hayfever: an Australian multicenter study ', Pediatric Allergy and Immunology, 22, (Epub ahead of print 30 September 2010) pp. 327-333. ISSN 0905-6157 (2010) [Refereed Article]

DOI: 10.1111/j.1399-3038.2010.01099.x [eCite] [Details]

Citations: Scopus - 53Web of Science - 49

Co-authors: van der Mei IAF

Tweet

2010Bahlo M, Stankovich J, Danoy P, Hickey PF, Taylor BV, et al., 'Saliva-Derived DNA Performs Well in Large-Scale, High-Density Single-Nucleotide Polymorphism Microarray Studies', Cancer Epidemiology, Biomarkers and Prevention, 19, (3) pp. 794-798. ISSN 1055-9965 (2010) [Refereed Article]

DOI: 10.1158/1055-9965.EPI-09-0812 [eCite] [Details]

Citations: Scopus - 23Web of Science - 21

Co-authors: Stankovich J; Foote SJ; Dickinson JL; Drysdale K; Guru P; Hoban E; McMorran BJ; Polanowski A; Whittock L; Perera D

Tweet

2010Lay ML, Lucas RM, Ratnamohan M, Taylor J, Ponsonby AL, et al., 'Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye ', Virology Journal, 7, (252) EJ ISSN 1743-422X (2010) [Refereed Article]

DOI: 10.1186/1743-422X-7-252 [eCite] [Details]

Citations: Scopus - 14Web of Science - 13

Co-authors: van der Mei I

Tweet

2010Riveros C, Mellor D, Gandhi KS, McKay FC, Cox MB, et al., 'A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in Multiple Sclerosis ', P L o S One, 5, (12) EJ ISSN 1932-6203 (2010) [Refereed Article]

DOI: 10.1371/journal.pone.0014176 [eCite] [Details]

Citations: Scopus - 28Web of Science - 26

Co-authors: Foote SJ; Stankovich J

Tweet

2010Simpson S, Taylor B, Blizzard L, Ponsonby AL, Pittas F, et al., 'Higher 25-hydroxyvitamin D Is Associated with Lower Relapse Risk in Multiple Sclerosis', Annals of Neurology, 68, (2) pp. 193-203. ISSN 0364-5134 (2010) [Refereed Article]

DOI: 10.1002/ana.22043 [eCite] [Details]

Citations: Scopus - 264Web of Science - 217

Co-authors: Simpson S; Blizzard L; Pittas F; van der Mei I

Tweet

2010Taylor BV, Lucas RM, Dear K, Kilpatrick TJ, Pender MP, et al., 'Latitudinal variation in incidence and type of first central nervous system demyelinating events', Multiple Sclerosis, 16, (4) pp. 398-405. ISSN 1352-4585 (2010) [Refereed Article]

DOI: 10.1177/1352458509359724 [eCite] [Details]

Citations: Scopus - 60Web of Science - 52

Co-authors: van der Mei IAF

Tweet

2010Taylor BV, Pearson JF, Clarke G, Mason DF, Abernethy DA, et al., 'MS prevalence in New Zealand, an ethnically and latitudinally diverse country ', Multiple Sclerosis, 16, (12) pp. 1422-1431. ISSN 1352-4585 (2010) [Refereed Article]

DOI: 10.1177/1352458510379614 [eCite] [Details]

Citations: Scopus - 52Web of Science - 46

Tweet

2010Field J, Browning SR, Johnson LJ, Danoy P, Varney MD, et al., 'A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis', PLoS ONE, 5, (10) EJ ISSN 1932-6203 (2010) [Refereed Article]

DOI: 10.1371/journal.pone.0013454 [eCite] [Details]

Citations: Scopus - 30Web of Science - 23

Co-authors: Charlesworth JC; Foote SJ; Stankovich J

Tweet

2010Jensen CJ, Stankovich J, Van der Walt A, Bahlo M, Taylor BV, et al., 'Multiple Sclerosis Susceptibility-Associated SNPs Do Not Influence Disease Severity Measures in a Cohort of Australian MS Patients', P L o S One, 5, (4) EJ ISSN 1932-6203 (2010) [Refereed Article]

DOI: 10.1371/journal.pone.0010003 [eCite] [Details]

Citations: Scopus - 28Web of Science - 24

Co-authors: Stankovich J; van der Mei IAF; Foote SJ

Tweet

2009Bahlo M, Booth DR, Broadley SA, Brown MA, Foote SJ, et al., 'Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20', Nature Genetics, 41, (7) pp. 824-830. ISSN 1061-4036 (2009) [Refereed Article]

DOI: 10.1038/ng.396 [eCite] [Details]

Citations: Scopus - 348Web of Science - 277

Co-authors: Foote SJ; Stankovich J; Drysdale KE; Mayura Guru P; McMorran BJ; Perera DI

Tweet

2009Dickinson JL, Perera DI, van der Mei AF, Ponsonby AL, Polanowski AM, et al., 'Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction ', Multiple Sclerosis, 15, (5) pp. 563-570. ISSN 1352-4585 (2009) [Refereed Article]

DOI: 10.1177/1352458509102459 [eCite] [Details]

Citations: Scopus - 52Web of Science - 47

Co-authors: Dickinson JL; Perera DI; van der Mei AF; Ponsonby AL; Polanowski AM; Thomson RJ; Stankovich J; Dwyer T

Tweet

2009Lucas RM, Ponsonby AL, Dear K, Taylor BV, Dwyer T, et al., 'Associations between Silicone Skin Cast Score, Cumulative Sun Exposure, and Other Factors in the Ausimmune Study: A Multicenter Australian Study ', Cancer Epidemiology, Biomarkers and Prevention, 18, (11) pp. 2887-2894. ISSN 1055-9965 (2009) [Refereed Article]

DOI: 10.1158/1055-9965 [eCite] [Details]

Citations: Scopus - 29Web of Science - 27

Co-authors: Van der Mei IAF

Tweet

2009Perera DI, Stankovich J, Butzkueven H, Taylor BVM, Foote SJ, et al., 'Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus', Journal of Neuroimmunology, 211, (25) pp. 105-109. ISSN 0165-5728 (2009) [Refereed Article]

DOI: 10.1016/j.jneuroim.2009.03.010 [eCite] [Details]

Citations: Scopus - 21Web of Science - 22

Co-authors: Perera DI; Stankovich J; Foote SJ

Tweet

2009Pittas F, Ponsonby AL, Van der Mei IAF, Taylor BVM, Blizzard CL, et al., 'Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis ', Journal of Neurology: Official Journal of The European Neurological Society, 256, (4) pp. 577-585. ISSN 0340-5354 (2009) [Refereed Article]

DOI: 10.1007/s00415-009-0120-2 [eCite] [Details]

Citations: Scopus - 68Web of Science - 62

Co-authors: Pittas F; Ponsonby AL; Van der Mei IAF; Blizzard CL; Groom PS; Dwyer T

Tweet

2009Stankovich J, Butzkueven H, Marriott M, Chapman C, Tubridy N, et al., 'HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis', Tissue Antigens, 74, (1) pp. 17-21. ISSN 0001-2815 (2009) [Refereed Article]

DOI: 10.1111/j.1399-0039.2009.01262.x [eCite] [Details]

Citations: Scopus - 30Web of Science - 25

Co-authors: Stankovich J; Foote SJ

Tweet

2009Young J, Quinn S, Hurrell M, Taylor B, 'Clinically isolated acute transverse myelitis: prognostic features and incidence', Multiple Sclerosis, 15, (11) pp. 1295-1302. ISSN 1352-4585 (2009) [Refereed Article]

DOI: 10.1177/1352458509345906 [eCite] [Details]

Citations: Scopus - 27Web of Science - 24

Tweet

2009Young JW, Mason DF, Taylor BV, 'Acute inflammatory encephalomyelitis following Campylobacter enteritis associated with high titre antiganglioside GM1 IgG antibodies', Journal of Clinical Neuroscience, 16, (4) pp. 597-598. ISSN 0967-5868 (2009) [Refereed Article]

DOI: 10.1016/j.jocn.2008.05.028 [eCite] [Details]

Citations: Scopus - 2Web of Science - 1

Tweet

2009van der Walt A, Stankovich J, Bahlo M, Taylor BV, van der Mei IAF, et al., 'Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy', Neurology, 73, (13) pp. 1018-1025. ISSN 0028-3878 (2009) [Refereed Article]

DOI: 10.1212/WNL.0b013e3181b9c85e [eCite] [Details]

Citations: Scopus - 33Web of Science - 26

Co-authors: Stankovich J; van der Mei IAF; Foote SJ

Tweet

2008Arthur AT, Armati PJ, Bye C, Kilpatrick TJ, Foote SJ, et al., 'Genes implicated in multiple sclerosis pathogenesis fromconsilience of genotyping and expression profiles in relapse and remission', BMC Medical Genetics, 9, (Mar 19) pp. 17. ISSN 1471-2350 (2008) [Refereed Article]

DOI: 10.1186/1471-2350-9-17 [eCite] [Details]

Citations: Scopus - 39Web of Science - 38

Co-authors: Foote SJ; Stankovich J

Tweet

2008Burfoot RK, Jensen CJ, Field J, Stankovich J, Varney MD, et al., 'SNP mapping and candidate gene sequencing in the class 1 region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians', Tissue Antigens, 71, (Oct 30) pp. 42-50. ISSN 0001-2815 (2008) [Refereed Article]

DOI: 10.1111/j.1399-0039.2007.00962.x [eCite] [Details]

Citations: Scopus - 38Web of Science - 34

Co-authors: Stankovich J; Foote SJ

Tweet

2008Butzkueven H, Kolbe SC, Jolley DJ, Brown JY, Cook MJ, et al., 'Validation of linear cerebral atrophy markers in multiple sclerosis', Journal of Clinical Neuroscience, 15, (2) pp. 130-137. ISSN 0967-5868 (2008) [Refereed Article]

DOI: 10.1016/jjocn.2007.02.089 [eCite] [Details]

Citations: Scopus - 23Web of Science - 23

Co-authors: Van der Mei IAF; Groom PS

Tweet

2008D'Souza WJ, Fryer JL, Quinn SJ, Taylor BVM, Ficker DM, et al., 'The Tasmanian Epilepsy Register - A Community-Based Cohort: Background and methodology for patient recruitment from the Australian national prescription database', Neuroepidemiology, 29, (3-4) pp. 255-263. ISSN 0251-5350 (2008) [Refereed Article]

DOI: 10.1159/000112859 [eCite] [Details]

Citations: Scopus - 17Web of Science - 17

Co-authors: D'Souza WJ; Fryer JL; Quinn SJ

Tweet

2008Dwyer T, Van der Mei IAF, Ponsonby AL, Taylor BVM, Stankovich J, et al., 'Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis', Neurology, 71, (8) pp. 583-589. ISSN 0028-3878 (2008) [Refereed Article]

DOI: 10.1212/01.wnl.0000323928.57408.93 [eCite] [Details]

Citations: Scopus - 30Web of Science - 30

Co-authors: Dwyer T; Van der Mei IAF; Ponsonby AL; Stankovich J; Thomson Russell; Polanowski AM; Dickinson JL

Tweet

2008Husain S, Yildirim-Toruner C, Rubio JP, Field J, Kilpatrick TJ, et al., 'Variants of ST8SIA1 Are Associated with Risk of Developing Multiple Sclerosis', PLoS One, 3, (7) pp. e2653. ISSN 1932-6203 (2008) [Refereed Article]

DOI: 10.1371/journal.pone.0002653 [eCite] [Details]

Citations: Scopus - 7Web of Science - 7

Co-authors: Foote SJ; Stankovich J

Tweet

2008Murphy M, Quinn SJ, Young J, Parkin P, Taylor BVM, 'Increasing incidence of ALS in Canterbury, New Zealand: A 22-year study', Neurology, 71, (23) pp. 1889-1895. ISSN 0028-3878 (2008) [Refereed Article]

DOI: 10.1212/01.wnl.0000336653.65605.ac [eCite] [Details]

Citations: Scopus - 61Web of Science - 50

Co-authors: Quinn SJ

Tweet

2008Rubio JP, Stankovich J, Field J, Tubridy N, Marriott M, et al., 'Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians', Genes and Immunity, 9, (7) pp. 624-630. ISSN 1466-4879 (2008) [Refereed Article]

DOI: 10.1038/gene.2008.59 [eCite] [Details]

Citations: Scopus - 91Web of Science - 86

Co-authors: Stankovich J; Perera DI; Foote SJ

Tweet

2008Tremlett H, Van der Mei IAF, Pittas F, Blizzard CL, Paley GA, et al., 'Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing doses', Pharmacoepidemiology and Drug Safety, 17, (6) pp. 565-576. ISSN 1053-8569 (2008) [Refereed Article]

DOI: 10.1002/pds.1593 [eCite] [Details]

Citations: Scopus - 45Web of Science - 43

Co-authors: Van der Mei IAF; Pittas F; Blizzard CL; Paley GA

Tweet

2008Tremlett H, Van der Mei IAF, Pittas F, Blizzard CL, Paley GA, et al., 'Monthly ambient sunlight, infections and relapse rates in multiple sclerosis', Neuroepidemiology, 31, (4) pp. 271-279. ISSN 0251-5350 (2008) [Refereed Article]

DOI: 10.1159/000166602 [eCite] [Details]

Citations: Scopus - 100Web of Science - 86

Co-authors: Van der Mei IAF; Pittas F; Blizzard CL; Paley GA; Mesaros D; Wood-Baker R; Nunez M; Dwyer T; Ponsonby AL

Tweet

2008Wray BN, Stankovich J, Whittock LD, Dwyer T, Ponsonby AL, et al., 'CTLA-4 and multiple sclerosis: The A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population', Journal of Neuroimmunology, 196, (1-2) pp. 139-142. ISSN 0165-5728 (2008) [Refereed Article]

DOI: 10.1016/j.jneuroim.2008.02.001 [eCite] [Details]

Citations: Scopus - 9Web of Science - 7

Co-authors: Wray BN; Stankovich J; Whittock LD; Van der Mei IAF; Dickinson JL; Foote SJ; McMorran BJ

Tweet

2007Lucas RM, Ponsonby AL, McMichael AJ, Van der Mei IAF, Chapman C, et al., 'Observational analytic studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multicentre Study of Environment and Immune Function', Multiple Sclerosis, 13, (7) pp. 827-839. ISSN 1352-4585 (2007) [Refereed Article]

DOI: 10.1177/1352458507077174 [eCite] [Details]

Citations: Scopus - 29Web of Science - 28

Co-authors: Ponsonby AL; Van der Mei IAF; Dwyer T

Tweet

2007Rubio JP, Bahlo M, Stankovich J, Burfoot RK, Johnson LJ, et al., 'Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class 1 region in Tasmanian MS patients', Immunogenetics, 59, (3) pp. 177-186. ISSN 0093-7711 (2007) [Refereed Article]

DOI: 10.1007/s00251-006-0183-5 [eCite] [Details]

Citations: Scopus - 9Web of Science - 9

Co-authors: Stankovich J; Foote SJ

Tweet

2007Taylor BV, McDonald E, Fantino B, Sedal L, MacDonnell R, et al., 'The cost of multiple sclerosis in Australia ', Journal of Clinical Neuroscience, 14, (6) pp. 532-539. ISSN 0967-5868 (2007) [Refereed Article]

DOI: 10.1016/j.jocn.2006.08.007 [eCite] [Details]

Citations: Scopus - 19Web of Science - 18

Tweet

2007Taylor BV, Williamson J, Jones D, Coleman D, Luck J, et al., 'Utility of serum Campylobacter specific antibodies in determining prior Campylobacter infection in neurological disease', Journal of Clinical Neuroscience, 14, (2) pp. 116-121. ISSN 0967-5868 (2007) [Refereed Article]

DOI: 10.1016/j.jocn.2006.01.040 [eCite] [Details]

Citations: Scopus - 5Web of Science - 5

Tweet

2007Van der Mei IAF, Ponsonby AL, Dwyer T, Blizzard CL, Taylor BV, et al., 'Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia', Journal of Neurology, 254, (5) pp. 581-590. ISSN 0340-5354 (2007) [Refereed Article]

DOI: 10.1007/s00415-006-0315-8 [eCite] [Details]

Citations: Scopus - 211Web of Science - 171

Co-authors: Van der Mei IAF; Ponsonby AL; Dwyer T; Blizzard CL

Tweet

2007Stewart NJ, Taylor BVM, Ponsonby AL, Pittas F, Van der Mei IAF, et al., 'The effect of season on cytokine expression in multiple sclerosis and healthy subjects', Journal of Neuroimmunology, 188, (1-2) pp. 181-186. ISSN 0165-5728 (2007) [Refereed Article]

DOI: 10.1016/j.jneuroim.2007.06.012 [eCite] [Details]

Citations: Scopus - 19Web of Science - 18

Co-authors: Stewart NJ; Ponsonby AL; Pittas F; Van der Mei IAF; Woods GM; Walters EH

Tweet

2006Mujic A, Hunn AWM, Taylor BV, Lowenthal RM, 'Extracranial metastases of a glioblastoma multiforme to the pleura, small bowel and pancreas', Journal of Clinical Neuroscience, 13, (6) pp. 677-681. ISSN 0967-5868 (2006) [Refereed Article]

DOI: 10.1016/j.jocn.2005.08.016 [eCite] [Details]

Citations: Scopus - 20Web of Science - 17

Tweet

2006Lowenthal RM, Taylor BV, Jones R, Beasley A, 'Severe persistent sciatic pain and weakness due to a gluteal artery pseudoaneurysm as a complication of bone marrow biopsy', Journal of Clinical Neuroscience, 13, (3) pp. 384-385. ISSN 0967-5868 (2006) [Refereed Article]

DOI: 10.1016/j.jocn.2005.03.027 [eCite] [Details]

Citations: Scopus - 11Web of Science - 8

Co-authors: Lowenthal RM; Jones R; Beasley A

Tweet

2006Taylor BV, 'Diabetic nerve vulnerability to ischaemia', Journal Watch Neurology, 8 pp. 51-52. ISSN 1524-0207 (2006) [Contribution to Refereed Journal]

[eCite] [Details]

2006Ponsonby AL, Dwyer T, Van der Mei IAF, Kemp A, Blizzard CL, et al., 'Asthma onset prior to multiple sclerosis and the contribution of sibling exposure in early life', Clinical and Experimental Immunology, 146, (3) pp. 463-470. ISSN 0009-9104 (2006) [Refereed Article]

DOI: 10.1111/j.1365-2249.2006.03235.x [eCite] [Details]

Citations: Scopus - 24Web of Science - 24

Co-authors: Ponsonby AL; Dwyer T; Van der Mei IAF; Blizzard CL

Tweet

2005Ostberg A, Pittas F, Taylor BVM, 'Use of low-dose mitozantrone to treat aggressive multiple sclerosis: a single-centre open-label study using patient self-assessment and clinical measures of multiple sclerosis status', Internal Medicine Journal, 35, (7) pp. 382-387. ISSN 1444-0903 (2005) [Refereed Article]

DOI: 10.1111/j.1445-5994.2005.00862.x [eCite] [Details]

Citations: Scopus - 10Web of Science - 10

Co-authors: Pittas F

Tweet

2005Ponsonby AL, Van der Mei IAF, Dwyer T, Blizzard CL, Taylor BV, et al., 'Birth order, infection in early life, and multiple sclerosis', The Lancet Neurology, 4, (12) pp. 793-794. ISSN 1474-4422 (2005) [Contribution to Refereed Journal]

DOI: 10.1016/S1474-4422(05)70233-7 [eCite] [Details]

Citations: Scopus - 3

Co-authors: Ponsonby AL; Van der Mei IAF; Dwyer T; Blizzard CL

Tweet

2005Ponsonby AL, Van der Mei IAF, Dwyer T, Blizzard CL, Taylor BVM, et al., 'Exposure to infant siblings during early life and risk of multiple sclerosis: reply to Ruprecht and Peron', Journal of the American Medical Association, 293, (17) pp. 2089-2090. ISSN 0098-7484 (2005) [Letter or Note in Journal]

PMID: 15870407 [eCite] [Details]

Citations: Scopus - 4

Co-authors: Ponsonby AL; Van der Mei IAF; Dwyer T; Blizzard CL

Tweet

2005Ponsonby AL, Van der Mei IAF, Dwyer T, Blizzard CL, Taylor BVM, et al., 'Exposure to infant siblings during early life and risk of multiple sclerosis', Journal of the American Medical Association, 293, (4) pp. 463-469. ISSN 0098-7484 (2005) [Refereed Article]

DOI: 10.1001/jama.293.4.463 [eCite] [Details]

Citations: Scopus - 113Web of Science - 93

Co-authors: Ponsonby AL; Van der Mei IAF; Dwyer T; Blizzard CL

Tweet

2005Sinnreich M, Taylor BV, Dyck P, 'Diabetic neuropathies. Classification, clinical features, and pathophysiological basis', The Neurologist, 11, (2) pp. 63-79. ISSN 1074-7931 (2005) [Refereed Article]

DOI: 10.1097/01.nrl.0000156314.24508.ed [eCite] [Details]

Citations: Scopus - 95Web of Science - 73

Tweet

2004Kilpatrick TJ, Butzkueven H, Emery B, Marriott M, Taylor BV, et al., 'Neuroglial responses to CNS injury: prospects for novel therapeutics', Expert Review of Neurotherapeutics, 4, (5) pp. 869-878. ISSN 1744-8360 (2004) [Refereed Article]

DOI: 10.1586/14737175.4.5.869 [eCite] [Details]

Citations: Scopus - 2

Tweet

2004Rubio JP, Bahlo M, Tubridy N, Stankovich J, Burfoot R, et al., 'Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis', Human Genetics, 114, (6) pp. 573-580. ISSN 0340-6717 (2004) [Refereed Article]

DOI: 10.1007/s00439-004-1095-9 [eCite] [Details]

Citations: Scopus - 34Web of Science - 29

Co-authors: Stankovich J; Foote SJ

Tweet

2004Taylor BV, Dunne JW, 'Diabetic amyotrophy progressing to severe quadriparesis', Muscle & Nerve, 30, (4) pp. 505-509. ISSN 0148-639X (2004) [Refereed Article]

DOI: 10.1002/mus.20107 [eCite] [Details]

Citations: Scopus - 7Web of Science - 5

Tweet

2004Taylor BV, Dyck PJB, Engelstad J, Gruener G, Grant I, et al., 'Multifocal motor neuropathy: pathologic alterations at the site of conduction block', Journal of Neuropathology and Experimental Neurology, 63, (2) pp. 129-137. ISSN 0022-3069 (2004) [Refereed Article]

DOI: 10.1093/jnen/63.2.129 [eCite] [Details]

Citations: Scopus - 76Web of Science - 65

Tweet

2004Taylor BV, Williamson J, Luck J, Coleman D, Jones D, et al., 'Sensitivity and specificity of serology in determining recent acute Campylobacter infection', Internal Medicine Journal, 34, (5) pp. 250-258. ISSN 1444-0903 (2004) [Refereed Article]

DOI: 10.1111/j.1444-0903.2004.00517.x [eCite] [Details]

Citations: Scopus - 17Web of Science - 16

Tweet

2003Hancock N, Poon M, Taylor BV, McLean C, 'Hereditary diffuse leucoencephalopathy with spheroids', Journal of Neurology, Neurosurgery and Psychiatry, 74, (9) pp. 1345-1347. ISSN 0022-3050 (2003) [Refereed Article]

DOI: 10.1136/jnnp.74.9.1345 [eCite] [Details]

Citations: Scopus - 31Web of Science - 28

Tweet

2003Mujic A, Hunn AWM, Liddell J, Taylor BV, Havlat M, et al., 'Isolated unilateral hypoglossal nerve paralysis caused by an atlanto-occipital joint synovial cyst', Journal of Clinical Neuroscience, 10, (4) pp. 492-495. ISSN 0967-5868 (2003) [Refereed Article]

DOI: 10.1016/S0967-5868(03)00083-3 [eCite] [Details]

Citations: Scopus - 14Web of Science - 14

Co-authors: Hunn AWM; Liddell J; Havlat M

Tweet

2003Van der Mei IAF, Ponsonby AL, Dwyer T, Blizzard CL, Simmons R, et al., 'Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study', British Medical Journal, 327, (7410) pp. 316-320. ISSN 0959-535X (2003) [Refereed Article]

DOI: 10.1136/bmj.327.7410.316 [eCite] [Details]

Citations: Scopus - 366Web of Science - 289

Co-authors: Van der Mei IAF; Ponsonby AL; Dwyer T; Blizzard CL

Tweet

2003Kagerer FA, Summers JJ, Byblow WD, Taylor B, 'Altered Corticomotor Representation in Patients with Parkinson's Disease', Movement Disorders, 18, (8) pp. 919-927. ISSN 0885-3185 (2003) [Refereed Article]

DOI: 10.1002/mds.10452 [eCite] [Details]

Citations: Scopus - 11Web of Science - 10

Co-authors: Kagerer FA; Summers JJ

Tweet

2002Rubio J, Bahlo M, Butzkueven H, Van der Mei IAF, Sale MM, et al., 'Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis', American Journal of Human Genetics, 70, (5) pp. 1125-1137. ISSN 0002-9297 (2002) [Refereed Article]

DOI: 10.1086/339932 [eCite] [Details]

Citations: Scopus - 75Web of Science - 68

Co-authors: Van der Mei IAF; Sale MM; Dickinson JL; Groom PS; Dwyer T; Foote SJ

Tweet

2001Taylor BV, 'Grand rounds a 24 year old man with upper limb weakness, pain and sensory loss. Case report and comments', Journal of The Neuromusculoskeletal System, 9, (3) pp. 103-107. ISSN 1067-8239 (2001) [Refereed Article]

[eCite] [Details]

2000Lowenthal RM, Taylor BV, Tan BS, 'Cold sweat case report', The Lancet, 356, (16 December) pp. 2064. ISSN 0140-6736 (2000) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Lowenthal RM

2000Taylor BV, Wright RA, Harper CM, Dyck PJ, 'Natural history of 46 patients with multifocal motor neuropathy with conduction block', Muscle and Nerve, 23, (6) pp. 900-908. ISSN 0148-639X (2000) [Refereed Article]

DOI: 10.1002/(SICI)1097-4598(200006)23:6<900::AID-MUS9>3.0.CO;2-Y [eCite] [Details]

Citations: Web of Science - 114

Tweet

1998Go RS, Taylor BV, Kimmel DW, 'The natural history of asymptomatic meningiomas in Olmsted County, Minnesota', Neurology, 51, (6) pp. 1718-1720. ISSN 0028-3878 (1998) [Refereed Article]

[eCite] [Details]

Citations: Web of Science - 35

1998Taylor BV, Buckner JC, Cascino TL, O'Fallon JR, Schaefer PL, et al., 'Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma', Journal of Clinical Oncology, 16, (6) pp. 2195-2201 . ISSN 0732-183X (1998) [Refereed Article]

DOI: 10.1200/JCO.1998.16.6.2195 [eCite] [Details]

Citations: Scopus - 70Web of Science - 65

Tweet

1998Taylor BV, Phillips BA, Speed BR, Kaldor J, Carroll WM, et al., 'Serological evidence for infection with Campylobacter jejuni/coli in patients with multifocal motor neuropathy', Journal of Clinical Neuroscience, 5, (1) pp. 33-35. ISSN 0967-5868 (1998) [Refereed Article]

DOI: 10.1016/S0967-5868(98)90198-9 [eCite] [Details]

Citations: Web of Science - 4

Tweet

1997Taylor BV, Kimmel DW, Krecke KN, Cascino TL, 'Magnetic resonance imaging in cancer-related lumbosacral plexopathy', Mayo Clinic Proceedings, 72, (9) pp. 823-829. ISSN 0025-6196 (1997) [Refereed Article]

DOI: 10.4065/72.9.823 [eCite] [Details]

Citations: Web of Science - 35

Tweet

1996Taylor BV, Gross L, Windebank AJ, 'The sensitivity and specificity of anti-GM1 antibody testing ', Neurology, 47, (4) pp. 951-955 . ISSN 0028-3878 (1996) [Refereed Article]

DOI: 10.1212/WNL.47.4.951 [eCite] [Details]

Citations: Web of Science - 86

Tweet

1995Kermode AG, Ives FJ, Taylor B, Davis SJ, Carroll WM, 'Progressive dural venous sinus thrombosis treated with local streptokinase infusion', Journal of Neurology, Neurosurgery and Psychiatry, 58, (1) pp. 107-108. ISSN 0022-3050 (1995) [Letter or Note in Journal]

[eCite] [Details]

1995Taylor BV, Mastaglia FL, Stell R, 'Guillain-Barre syndrome complicating treatment with streptokinase', Medical Journal of Australia, 162, (4) pp. 214-215. ISSN 0025-729X (1995) [Refereed Article]

[eCite] [Details]

Citations: Web of Science - 4

1995Taylor BV, Wijdicks EF, Poterucha JJ, Weisner RH, 'Chronic inflammatory demyelinating polyneuropathy complicating liver transplantation', Annals of Neurology, 38, (5) pp. 828-831. ISSN 0364-5134 (1995) [Refereed Article]

DOI: 10.1002/ana.410380519 [eCite] [Details]

Citations: Scopus - 26Web of Science - 20

Tweet

1994Anderson CS, Taylor BV, Hankey GJ, Stewart-Wynne EG, Jamrozik KD, 'Validation of a clinical classification for subtypes of acute cerebral infarction', Journal of Neurology, Neurosurgery and Psychiatry, 57, (10) pp. 1173-1179. ISSN 0022-3050 (1994) [Refereed Article]

DOI: 10.1136/jnnp.57.10.1173 [eCite] [Details]

Citations: Scopus - 66Web of Science - 51

Tweet

Chapter in Book

(1 outputs)
YearCitationAltmetrics
2003Taylor BV, 'The Treatment of Multifocal Motor Neuropathy with Conduction Block (MMN-CB)', Neurological Therapeutics: Principles and Practice, Martin Dunitz, Noseworthy JH (ed), London and New York, pp. 2111-2116. ISBN 1-85317-623-0 (2003) [Other Book Chapter]

[eCite] [Details]

Review

(6 outputs)
YearCitationAltmetrics
2012Lin R, Charlesworth J, van der Mei I, Taylor BV, 'The genetics of multiple sclerosis', Practical Neurology, 12, (5) pp. 279-288. ISSN 1474-7758 (2012) [Substantial Review]

DOI: 10.1136/practneurol-2012-000276 [eCite] [Details]

Citations: Scopus - 19

Co-authors: Charlesworth J; van der Mei I

Tweet

2012O'Gorman C, Lucas R, Taylor B, 'Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms', International Journal of Molecular Sciences, 13, (9) pp. 11718-11752. ISSN 1422-0067 (2012) [Substantial Review]

DOI: 10.3390/ijms130911718 [eCite] [Details]

Citations: Scopus - 40

Tweet

2011Simpson Jr S, Greenhill K, Van der Mei I, Stankovich J, Charlesworth J, et al., 'The Varied Mechanisms of Vitamin D in the Onset and Clinical Course of MS: Potential Roles in Modulating Other Etiological Pathways', Current Medical Literature. Neurology, 27, (1) pp. 1-14. (2011) [Substantial Review]

[eCite] [Details]

Co-authors: Simpson Jr S; Greenhill K; Van der Mei I; Stankovich J; Charlesworth J

2011Taylor BV, 'The major cause of multiple sclerosis is environmental: genetics has a minor role - Yes', Multiple Sclerosis Journal, 17, (10) pp. 1171-1173. (2011) [Substantial Review]

DOI: 10.1177/1352458511421105 [eCite] [Details]

Citations: Scopus - 15

Tweet

2011Van der Mei IAF, Simpson JR S, Knippenberg S, Winzenberg T, Taylor BV, 'Role of vitamin D in multiple sclerosis: implications for disease management', Neurodegenerative Disease Management, 1, (6) pp. 523-536. (2011) [Substantial Review]

DOI: 10.2217/NMT.11.59 [eCite] [Details]

Co-authors: Van der Mei IAF; Simpson JR S; Winzenberg T

Tweet

2011Van der Mei IAF, Simpson Jr S, Stankovich J, Taylor BV, 'Individual and Joint Action of Environmental Factors and Risk of MS', Neurologic Clinics , 29, (2) pp. 233-255. (2011) [Substantial Review]

DOI: 10.1016/j.ncl.2010.12.007 [eCite] [Details]

Citations: Scopus - 38

Co-authors: Van der Mei IAF; Simpson Jr S; Stankovich J

Tweet

Conference Publication

(32 outputs)
YearCitationAltmetrics
2016Ahmad H, van der Mei I, Taylor B, Palmer AJ, 'PND13 - Assessing Health-State Utility Values in Australian People with Multiple Sclerosis', Value in Health, pp. A875, 19 (7). (2016) [Conference Extract]

DOI: 10.1016/j.jval.2016.08.342 [eCite] [Details]

Co-authors: Ahmad H; van der Mei I; Palmer AJ

Tweet

2016Bostock ECS, Kirkby KC, Garry MI, Taylor BVM, 'Comparison of cognitive function in euthymic bipolar disorder and focal epilepsy arising from the temporal lobes: Systematic review', Bipolar Disorders Supplement, 14-17 July, 2016, Amsterdam, Netherlands, pp. 42. ISSN 1399-2406 (2016) [Conference Extract]

DOI: 10.1111/bdi.12407 [eCite] [Details]

Co-authors: Bostock ECS; Kirkby KC; Garry MI

Tweet

2016Palmer AJ, Taylor B, Van der Mei I, Si L, Ahmad H, 'CU3 - Life Expectancy, Quality-Adjusted Life Years, and Total Lifetime Costs for Australian People with Multiple Sclerosis', Value in Health, pp. A808, 19 (7). (2016) [Conference Extract]

DOI: 10.1016/j.jval.2016.08.722 [eCite] [Details]

Co-authors: Palmer AJ; Van der Mei I; Si L; Ahmad H

Tweet

2015Bostock ECS, Kirkby KC, Garry MI, Taylor BVM, 'Concurrence of precipitating factors in mania and partial seizures arising from the temporal lobes', Australasian Society for Bipolar and Depressive Disorders Conference, 8-10 November, 2015, Sydney, Australia (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Bostock ECS; Kirkby KC; Garry MI

2015Zhou Y, Zhu GA, Nyholt DR, Charlesworth JC, Simpson JR Steve, et al., 'Multiple Quantitative Trait Loci for Anti-EBNA-1 IgG Titres are Associated with Risk of Multiple Sclerosis', Multiple Sclerosis Journal, pp. 810. ISSN 1352-4585 (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Zhou Y; Zhu GA; Nyholt DR; Charlesworth JC; Simpson JR Steve; Van der Mei IAF

2015Bostock ECS, Kirkby KC, Garry MI, Taylor BVM, 'Overlap of precipitating factors in mania and partial seizures: in pursuit of shared pathophysiology', Bipolar Disorders. Supplement, 3-6 June, 2015, Toronto, Canada, pp. 79. ISSN 1399-2406 (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Bostock ECS; Kirkby KC; Garry MI

2015Landowski LM, Pavez M, Gasperini RJ, Taylor BVM, West AK, et al., 'Low-density lipoprotein receptor-related proteins guide navigating PNS axons', 2015 PNS Meeting, 28 June - 2 July, 2015, Quebec City, Canada (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Landowski LM; Pavez M; Gasperini RJ; West AK; Foa LC

2014Landowski LM, Pavez M, Gasperini RJ, Taylor BVM, West AK, et al., 'LRP receptors in a novel mechanism of axon pathfinding and peripheral nerve regeneration', Neuroscience 2014, 15-19 November, 2014, Washington, DC (2014) [Conference Extract]

[eCite] [Details]

Co-authors: Landowski LM; Pavez M; Gasperini RJ; West AK; Foa LC

2014Landowski LM, Taylor BVM, West AK, Foa LC, 'Identification of novel neurotrophic-like factors: a candidate for promoting nerve regeneration in neuropathy', ANS Adelaide 2014, Jan 28-31, 2014, Adelaide, Australia (2014) [Conference Extract]

[eCite] [Details]

Co-authors: Landowski LM; West AK; Foa LC

2014Landowski LM, Pavez M, Gasperini RJ, Taylor BVM, West AK, et al., 'LRP receptors in a novel mechanism of axon pathfinding and peripheral nerve regeneration', Neuroscience 2014, November 15-19, 2015, Washington DC (2014) [Conference Extract]

[eCite] [Details]

Co-authors: Landowski LM; Pavez M; Gasperini RJ; West AK; Foa LC

2012Landowski LM, Gasperini RJ, Taylor BVM, West AK, Foa LC, 'Metallothionein I/II induces growth cone chemotaxis via an LRP 1 and LRP 2 dependent mechanism', Neuroscience 2012, 13-17 October, 2012, New Orleans, Louisiana (2012) [Conference Extract]

[eCite] [Details]

Co-authors: Landowski LM; Gasperini RJ; West AK; Foa LC

2012Lin R, Perreau V, Glazov E, McMorran B, Bahlo M, et al., 'Searching for rare variants conferring susceptibility to multiple sclerosis', Multiple Sclerosis Journal; Progress in MS Research Conference, 2011, Melbourne, Australia, pp. 701-702; Vol 18. (2012) [Conference Extract]

[eCite] [Details]

Co-authors: McMorran B; Foote S; Charlesworth J; Thomson R; Stankovich J

2012Landowski LM, Gasperini RJ, Taylor BVM, West AK, Foa LC, 'Metallothionein I/II induces growth cone chemotaxis via an LRP 1 and LRP 2 dependent mechanism', Neuroscience 2012, 13-17 October, 2012, New Orleans, Louisiana (2012) [Conference Extract]

[eCite] [Details]

Co-authors: Landowski LM; Gasperini RJ; West AK; Foa LC

2011Charlesworth JC, Glahn DC, Curran JE, Kochunov P, Stankovich J, et al., 'Using normal variation in neuroanatomic traits to identify genes and pathways influencing disease: a joint linkage and association analysis of brain lesions', Proceedings of the 8th GeneMappers Conference, 4-6 April 2011, Hotel Grand Chancellor, Hobart, Australia, pp. 56. (2011) [Conference Extract]

[eCite] [Details]

Co-authors: Charlesworth JC; Stankovich J

2011Landowski LM, Gasperini RJ, Small DH, Taylor BVM, West AK, et al., 'Metallothionein I/II and metallothionein III induce growth cone chemotaxis via disparate mechanisms', Australian Neuroscience Society 31st Annual Meeting, 31 Jan - 3 Feb, Auckland, New Zealand (2011) [Conference Extract]

[eCite] [Details]

Co-authors: Landowski LM; Gasperini RJ; Small DH; West AK; Foa LC

2010Lucas RM, Ponsonby AL, Burrows J, Chapman C, Coulthard A, et al., 'Epstein Barr viral infection and onset of central nervous system demyelination', Sage Publications Ltd, June, San Antonio, TX, pp. Vol. 16 (8) 1007. (2010) [Conference Edited]

[eCite] [Details]

Co-authors: Van der Mei IAF

2010Ponsonby AL, Lucas RM, Van der Mei IAF, Dear K, Taylor BVM, et al., 'Investigation of the role of pregnancy and exposure to biological children in the onset of central nervous system demyelination', Sage Publications Ltd, June, San Antonio, TX, pp. Vol 16 (8) p.1007-1008 . (2010) [Conference Edited]

[eCite] [Details]

Co-authors: Van der Mei IAF

2009van der Walt A, Stankovich J, Bahlo M, Taylor BVM, Van der Mei IAF, et al., 'The HLA-DR2 genotype does not affect MS severity, cognition or brain atrophy', Sage Publications Ltd, 9-12 September, Dusseldorf, Germany, pp. Vol 15 (9) p.183. (2009) [Conference Edited]

[eCite] [Details]

Co-authors: Stankovich J; Van der Mei IAF; Foote SJ

2008Tremlett H, Van der Mei IAF, Pittas F, Blizzard L, Paley GA, et al., 'Monthly ambient sunlight, vitamin D, infections and relapse rates in multiple sclerosis', Sage Publications Ltd, 17-20 September, Montreal, Canada, pp. Vol 14 (1) 203-204. (2008) [Conference Edited]

[eCite] [Details]

Co-authors: Van der Mei IAF; Pittas F; Blizzard L; Paley GA; Meszaros D; Wood-Baker R; Nunez M; Ponsonby AL

2008Van der Mei IAF, Ponsonby AL, Taylor BVM, Stankovich J, Dickinson JL, et al., 'A potentiation of the adverse effect of human leukocyte antigen-DR15 on the risk of multiple sclerosis by low infant sibling exposure: a population based case-control study', Sage Publications Ltd, 17-20 September, Montreal, Canada, pp. Vol 14 (1) S201-S202. (2008) [Conference Edited]

[eCite] [Details]

Co-authors: Van der Mei IAF; Stankovich J; Dickinson JL; Foote SJ

2008van der Walt A, Stankovich J, Bahlo M, Taylor BVM, Van der Mei IAF, et al., 'Apolipoprotein E4 genotype does not influence multiple sclerosis phenotype, severity, cognition or brain atrophy in a large Australian cohort', Sage Publications Ltd, 17-20 September, Montreal, Canada, pp. Vol 14 (1) S204. (2008) [Conference Edited]

[eCite] [Details]

Co-authors: Stankovich J; Van der Mei IAF; Foote SJ

2008Lucas R, Taylor BVM, Ponsonby AL, Chapman C, Coulthard A, et al., 'Latitudinal variation in incidence of first demyclinating events: descriptive analyses of case participants in the Ausimmune Study', Sage Publications Ltd, 17-20 September, Montreal, Canada, pp. Vol 14 (1) S190-S191. (2008) [Conference Edited]

[eCite] [Details]

Co-authors: Van der Mei IAF

2007Tremlett H, Van der Mei IAF, Pittas F, Blizzard L, Paley GA, et al., 'Who's missing out? Pharmionics and the immunomodulatory therapies for MS', Sage Publications, 11-14 October, Prague, Czech Republic, pp. Vol 13 (2) p.S47. (2007) [Conference Edited]

[eCite] [Details]

Co-authors: Van der Mei IAF; Pittas F; Blizzard L; Paley GA

2005Foote SJ, Rubio JP, Bahlo M, Kilpatrick TJ, Speed TP, et al., 'Multiple Sclerosis: a haplotype association study', Novartis Foundation Symposium, 2005, pp. 31-39. (2005) [Conference Extract]

[eCite] [Details]

Co-authors: Foote SJ; Stankovich J; Sale MM; Van der Mei IAF; Dickinson JL; Groom PS

2005Jones DL, Pittas F, McInerney G, Rush M, Taylor BV, 'OPL110 Clinical-MRI correlates in multiple sclerosis: Correlation of EDSS, MSFC, fatigue and depression measures with FLAIR, T1 volume and diffusion measures of normal-appearing white matter', Journal of the Neurological Sciences, pp. S74, 238 (Suppl. 1). (2005) [Conference Extract]

DOI: 10.1016/S0022-510X(05)80286-2 [eCite] [Details]

Co-authors: Jones DL; Pittas F

Tweet

2003Van der Mei IAF, Ponsonby AL, Dwyer T, Blizzard CL, Simmons R, et al., 'Past sun exposure, skin phenotype and risk of multiple sclerosis: a case-control study', 15th Conference of the International Society for Environmental Epidemiology, 24-26 September 2003, Perth, Australia (2003) [Conference Extract]

[eCite] [Details]

Co-authors: Van der Mei IAF; Ponsonby AL; Dwyer T; Blizzard CL

1999Jones D, Taylor BV, Coleman D, Williamson JC, Wan P, et al., 'The prevalence of potentialy neuropathic strains of Campylobacter within Tasmania using the Cholera toxin binding assay and pulse-field gel electrophoresis', Poster Display Abstract Booklet, 31st may - 4th June 1999, Royal Hobart Hospital, Hobart, Tasmania, pp. 17. (1999) [Conference Extract]

[eCite] [Details]

Co-authors: McGregor A

1999Taylor BV, Luck JC, Williamson J, Jones D, Coleman D, et al., 'The incidence of antibodies to Campylobacter species in healthy blood donors, patients with previous Campylobacter infections and patients with neurological disease', Poster Display Abstract Booklet, 31st may - 4th June 1999, Royal Hobart Hospital, Hobart, Tasmania, pp. 17-18. (1999) [Conference Extract]

[eCite] [Details]

Co-authors: McGregor A

1997Taylor BV, Kimmel DW, 'The natural history of asymptomatic meningiomas', Programme & Abstracts, Sydney, Australia, pp. 57. (1997) [Conference Extract]

[eCite] [Details]

1997Taylor BV, O'Fallon JR, Buckner J, Cascino TL, 'The effect of radiation therapy on the cognitive performance of high grade glioma patients', Programme & Abstracts, Sydney, Australia, pp. 58. (1997) [Conference Extract]

[eCite] [Details]

1997Taylor BV, Wright RA, Harper CM, Dyck PI, 'Clinical characteristics and longitudinal course of multifocal motor neuropathy with persistent conduction block (MMN-PCB)', Program and Abstracts, Cambridge, England, July 9-12, pp. 236. (1997) [Conference Extract]

[eCite] [Details]

1997Wright RA, Taylor BV, Harper CM, Dyck PJ, 'Electrophysiological characterization of multifocal motor neuropathy (MMN) with persistent motor conduction block (PCB)', Program and Abstracts, Cambridge, England, pp. 103. (1997) [Conference Extract]

[eCite] [Details]

Grants & Funding

Funding Summary

Number of grants

44

Total funding

$9,616,538

Projects

inforMS- a new patient-driven health care model for MS (2017 - 2018)$42,750
Description
The project aims:Stage 1: Completion of the inforMS prototypeData visualisation of existing research data (overview, basic tracking over time (outcomes/medications/behaviours); filtering (comparisons with grouped data).Patient involvement and feedbackModify the existing prototype to incorporate the suggested improvements and feedback.Stage 2: Work towards the completion of the full inforMS platformPlan for the addition of a Data Collection System: This allows patients to enter data in their own time and frequency.Set up the integration with MSBase (an international database operating in over 72 countries, where neurologists continually upload patients clinical data).
Funding
Multiple Sclerosis Research Australia ($42,750)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Taylor BVM
Period
2017 - 2018
inforMS - a new patient-driven health care model for MS (2017)$28,245
Description
The project aims:Stage 1: Completion of the inforMS prototypeIncludes data visualisation of existing research data (overview, basic tracking over time (outcomes/medications/behaviours); filtering (comparisons with grouped data).Patient involvement and feedbackStage 2: Completion of the full inforMS platformAdd a Data Collection System: This allows patients to enter data in their own time and frequency.Integration with MSBase (an international database operating in over 72 countries, where neurologists continually upload patients clinical data).Perform process evaluation with patients and neurologists/MS nurses to ensure good usability and optimal benefits.
Funding
Multiple Sclerosis Research Australia ($28,245)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Taylor BVM
Year
2017
Investigating the anti-inflammatory effect of a non-anticoagulant molecule of heparin following experimental traumatic brain injury (2017)$10,000
Description
Heparin has shown promising results in attenuating neuroinflammation following experimental traumatic brain injury (TBI); however, its anti-coagulative properties make it an unsuitable treatment due to the risk of bleeding. We have recently shown that the heparin derivative Dp4 retains the anti-inflammatory actions of heparin, but not the anti-coagulative properties. In this project, we will test whether Dp4 suppresses neuroinflammation following TBI in mice, potentially identifying it as a novel and valuable therapeutic agent for brain-injured patients.
Funding
Royal Hobart Hospital Research Foundation ($10,000)
Scheme
Grant-Starter
Administered By
University of Tasmania
Research Team
Bye N; Taylor BVM; Patel RP
Year
2017
What predicts the progressive phase of multiple sclerosis? (2017 - 2021)$1,791,343
Description
We have made major gains in our understanding of what causes MS. What has proven to be far more difficult is understanding the drivers ofdisability progression and conversion to progressive MS. The onset of progression heralds the accumulation of irreversible disability and is acritical time point to a person with MS. This grant aims to determine the lifestyle, environmental, genetic and epigenetic drivers of MSprogression, using an internationally unique Australian MS longitudinal cohort.
Funding
National Health & Medical Research Council ($1,791,343)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Taylor BVM; Scott RJ; van der Mei IAF; Lucas R; Ponsonby A; Lechner-Scott J; Lea R; Fox A; Broadley SA; Shaw C
Period
2017 - 2021
Grant Reference
1127819
Identifying novel genetic loci associated with an increased relapse rate and disability progression in multiple sclerosis (2017)$10,000
Description
Determining genetic drivers of MS clinical course requires meticulously collected prospective data in well characterised MS longitudinal cohorts. We have such a cohort but lack the comprehensive genotyping to allow this vital analysis. We seek assistance to complete genotyping this cohort
Funding
Royal Hobart Hospital Research Foundation ($10,000)
Scheme
Grant-Starter
Administered By
University of Tasmania
Research Team
Zhou Y; Taylor BVM
Year
2017
Generating and characterizing a reliable rodent model type 2 diabetes (2016)$14,673
Funding
University of Tasmania ($14,673)
Scheme
Grant-Research Enhancement (REGS)
Administered By
University of Tasmania
Research Team
Premilovac D; Foa LC; Taylor BVM; Guven N
Year
2016
Does treating multiple sclerosis alter long-term disease outcomes? a natural history study (2016 - 2017)$180,000
Description
A natural history study of MS outcomes between a treated (Australian) versus untreated NZ population to study the long-term effects of MS disease modifying drugs. This is a clinical epidemiological project.
Funding
Multiple Sclerosis Research Australia ($180,000)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Taylor BVM; van der Mei IAF; Palmer AJ; Blizzard CL; Butzkueven H; Simpson Jr S; Kalincik T; Carroll W; Mason D
Period
2016 - 2017
Select Foundation Fellowship - Prof Bruce Taylor (2016 - 2019)$500,000
Description
Relates to Fellowship No. 4
Funding
The Select Foundation ($500,000)
Scheme
Fellowship-Senior Research
Administered By
University of Tasmania
Research Team
Taylor BVM
Period
2016 - 2019
Creating an MS Portal to achieve better outcomes for people with MS (2015)$25,000
Description
The project aims to create and test a prototype of a web-based MS Portal that is beneficial for MS patients, health professionals, service delivery organisations and researchers. The project will: 1) conduct surveys and focus groups with stakeholder groups; 2) develop an ethical and logistical framework, and work through practical issues to allow the linkage of specific data sets to occur; 3) trial to set up an enduring linkage between AMSLS and MSBase; 4) design an MS Portal prototype and develop web access protocols; 5) test the MS Portal prototype with all stakeholder groups.
Funding
Multiple Sclerosis Research Australia ($25,000)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Stokes BC; Hornsby H; Taylor BVM; Butzkueven H
Year
2015
Promoting regrowth of nerve fibres into the epidermis during diabetic neuropathy by LRP agonists (2015 - 2017)$413,731
Funding
National Health & Medical Research Council ($413,731)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Foa LC; Taylor BVM; West AK; Keske MAV
Period
2015 - 2017
Grant Reference
1088952
DEVA MS: DEvelopment and VAlidation of a cost effectiveness simulation model for Multiple Sclerosis and implications for health policy (2015 - 2016)$160,000
Description
The number of people with multiple sclerosis (MS) is increasing dramatically in Australia, with rapidly escalating associated costs, both direct due to medical expenses and indirect due to lost or reduced employment. Existing and upcoming treatments for MS are expensive, with current prices of up to $25,000 per patient per year and rising. Using the best available data, this study will identify the treatments that are greatest value for money for the most common form of MS (relapsing-remitting MS), with a goal to reduce wastage of limited healthcare resources.
Funding
Multiple Sclerosis Research Australia ($160,000)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Palmer AJ; Taylor BVM; van der Mei IAF; Clarke Philip; Simpson Jr S
Period
2015 - 2016
Development of a therapeutic agent for a chemotherapy-induced neuropathy (2015)$21,739
Description
Chemotherapy-induced neuropathy (CIN) is a dose-limiting side effect of chemotherapy treatment, causing irreversible disability in 40% of cancer survivors. CIN results from the loss or damage of neurons during chemotherapy. We have compelling evidence that the protein metallothionein promotes regeneration of peripheral nerves, and examine its therapeutic use in CIN.This project will create new knowledge in the area of chemotherapy induced neuropathy, and establish the suitability of trophic agents as disease-modifying agents for chemotherapy-induced neuropathy.
Funding
Royal Hobart Hospital Research Foundation ($21,739)
Scheme
Grant-Clinical Research
Administered By
University of Tasmania
Research Team
Taylor BVM; Landowski LM; West AK; Vickers JC; Foa LC; Guven N
Year
2015
Case-control study in Primary Progressive MS: Are the risk factors the same as for people with RRMS onset and can we identify new ones? (2015 - 2016)$142,000
Description
Examining risk factors of disease by comparing cases with a disease to healthy controls has been critical in understanding the aetiology of diseases. In MS, for example, important progress has been made through the epidemiological findings that cases were more likely to have had infectious mononucleosis, have high anti-EBNA IgG titres, and have low sun exposure levels. These findings resulted in a large body of laboratory work focusing on the mechanisms behind these observations. We have previously conducted epidemiological case-control studies on MS, but the number of people with PPMS was always too low to conduct a sub-analysis to examine whether the risk factors that we identified were also important in those with PPMS. We now propose to conduct a case-control of PPMS in a very cost-effective way, by using the data already collected on a large sample of healthy controls (n=558) from the Ausimmune study. We aim to collect the same data from a sample of cases with PPMS in Australia and compare that to the controls of the Ausimmune study. Moreover, the longer-term vision is that this data will form the basis for a prospective longitudinal study, where the cases with PPMS will be followed over time, in order to examine factors that are associated with the progression of MS. This will then be important for identifying possible treatments in MS for people with PPMS. HypothesesEstablished risk factors in MS, including low sun exposure, infectious mononucleosis, smoking, high anti-EBV-EBNA IgG and HLA-DR15 genotype are associated with an increased risk of PPMS onset.Low parity, lack of younger sibling exposure and exposure to livestock are associated with an increased risk of PPMS.People with PPMS have a higher EBV DNA load in whole blood and altered EBV serology compared to people with a RRMS onset.
Funding
Multiple Sclerosis Research Australia ($142,000)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
van der Mei IAF; Taylor BVM; Ponsonby A; Lucas R; Simpson Jr S; Blizzard CL
Period
2015 - 2016
Australian MS Longitudinal study (2014 - 2018)$490,230
Description
The main objectives of this project are: a) to continue the established multi-disciplinary research database for Australia with MS that will provide answers to important questions about the disease that are not able to be addressed by projects funded in the normal, relatively short cycle of research grants; b) to encourage nationwide (and international) multi-disciplinary collaboration on MS research projects, utilising valid and reliable measures that are internationally accepted and compatible wherever possible, and to lead by example in the unification of Australia's efforts to solve the various problems associated with MS; c) to reduce the cost of multi-disciplinary research on MS by provision of a large, well-characterised cohort of volunteer subjects for future studies.
Funding
Multiple Sclerosis Research Australia ($490,230)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Taylor BVM
Period
2014 - 2018
Functional consequences of Multiple Sclerosis-associated genetic changes in Vitamin D metabolism genes in T cells and the pathogenesis of autoimmunity (2014 - 2015)$24,950
Description
It is now well recognised that the risk of developing Multiple Sclerosis (MS) is governed by a complex interplay between genetic and environmental factors. Genes within the vitamin D pathway have been implicated in MS risk as has lower levels of vitamin D. How these 2 factors interact to alter immunity and increase the risk of developing autoimmune disease is not clear. This project looks at the functional consequences of a change in the genetic code in known MS risk genes that are in the vitamin D metabolic pathway and how these changes alter the function of T lymphocytes, the immune cells thought to play a major role in the inflammation that is characteristic of MS.
Funding
Multiple Sclerosis Research Australia ($24,950)
Scheme
Grant-Incubator
Administered By
University of Tasmania
Research Team
Korner H; Taylor BVM
Period
2014 - 2015
The relationship between Immunoglobulin E (IgE), disease severity and the immune response in multiple sclerosis (2014)$15,300
Description
The immune system in people with multiple sclerosis (MS) is thought to favour inflammatory responses that preclude allergic reactions and the production of the antibody Immunoglobulin E (IgE). This project proposes that IgE levels are in fact high in some people with MS, and that this is protective. It proposes therefore to measure IgE levels in persons with MS and examine associations between IgE, disease severity and immune function.
Funding
Royal Hobart Hospital Research Foundation ($15,300)
Scheme
Grant-Clinical Research
Administered By
University of Tasmania
Research Team
Taylor BVM; Stewart NJ; Simpson Jr S
Year
2014
The role of environmental and genetic factors in progression of multiple sclerosis (2013 - 2016)$945,084
Description
Much is known regarding the factors that increase the risk of developing multiple sclerosis. However there is little data regarding the importance of these and other factors on the rate of progression of MS. Once the diagnosis of MS is made one of the critical issues for patients and treating physicians is; what will happen now? As there are currently no established modifiable risk factors for MS progression, this project aims to delineate potentially modifiable risk factors for MS progression.
Funding
National Health & Medical Research Council ($945,084)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Taylor BVM; van der Mei IAF; Lucas R; Blizzard CL; Coulthard A; Broadley SA; Williams D; Shaw C
Period
2013 - 2016
Grant Reference
1047180
Examining the role of blood lipids and apolipoproteins on the progression of MS in a prospective clinical cohort (2013)$22,109
Funding
Royal Hobart Hospital Research Foundation ($22,109)
Scheme
Grant-Clinical Research
Administered By
University of Tasmania
Research Team
Taylor BVM; van der Mei IAF; Lucas R; Kostner K; Simpson Jr S
Year
2013
Do metallothioneins promote and direct regenerative growth of epidermal nerve fibres in diabetic peripheral neuropathy? (2013)$33,000
Funding
Brain Foundation ($33,000)
Scheme
Grant-Research
Administered By
University of Tasmania
Research Team
West AK; Taylor BVM; Foa LC
Year
2013
The Cholecalciferol Intervention to Prevent Respiratory Infections Study (CIPRIS) (2012)$6,335
Funding
The Select Foundation ($6,335)
Scheme
Grant-Small Grants Scheme
Administered By
University of Tasmania
Research Team
Simpson Jr S; Taylor BVM; Stewart NJ; van der Mei IAF; Blizzard CL
Year
2012
A double-blind randomised controlled trial to evaluate the efficacy of 20,000 IU/wk cholecalciferol in reducing respiratory tract infection in a cohort of healthy young adults (2012)$22,256
Funding
Royal Hobart Hospital Research Foundation ($22,256)
Scheme
Grant-Clinical Research
Administered By
University of Tasmania
Research Team
Taylor BVM; Simpson Jr S; van der Mei IAF; Stewart NJ
Year
2012
The effect of vitamin D and Interferon-beta on the immune response (2012)$9,091
Funding
Royal Hobart Hospital Research Foundation ($9,091)
Scheme
Grant-Starter
Administered By
University of Tasmania
Research Team
Taylor BVM; Stewart NJ; Simpson Jr S
Year
2012
Environmental and genetic factors that influence the onset and progression of multiple sclerosis (2012 - 2014)$300,000
Funding
Royal Hobart Hospital Research Foundation ($300,000)
Scheme
Fellowship-Research
Administered By
University of Tasmania
Research Team
Taylor BVM
Period
2012 - 2014
Examining the role of lipids in the progression of MS in a prospective cohort study (2012 - 2013)$60,000
Funding
Multiple Sclerosis Research Australia ($60,000)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
van der Mei IAF; Taylor BVM; Blizzard CL; Ponsonby AL; Dwyer T; Kostner K
Period
2012 - 2013
Validating novel serum markers of neurodegeneration in Multiple Sclerosis patients (2010 - 2012)$498,625
Funding
National Health & Medical Research Council ($498,625)
Scheme
Grant-Project
Administered By
University of Melbourne
Research Team
Butzkueven H; Shaw Gerry; Taylor BVM
Period
2010 - 2012
Grant Reference
628799
Identifying rare genetic variants conferring susceptibility to multiple sclerosis (2010 - 2011)$286,350
Funding
National Health & Medical Research Council ($286,350)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Charlesworth JC; Perreau V; Gardiner Brooke; McMorran BJ; Taylor BVM; Browning S
Period
2010 - 2011
Grant Reference
605511
Prognostic factors following a first episode of central nervous system demyelination suggestive of multiple sclerosis (2009 - 2011)$689,575
Funding
National Health & Medical Research Council ($689,575)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Taylor BVM; van der Mei IAF; Lucas R; Coulthard A; Blizzard CL
Period
2009 - 2011
Grant Reference
544922
Effect of EBV and HHV-6 latent infection or reactivation on MS activity: a prospective clinical cohort study (2008)$258,500
Funding
National Health & Medical Research Council ($258,500)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
van der Mei IAF; Ponsonby AL; Taylor BVM; Dwyer D; Dwyer T; Blizzard CL
Year
2008
Grant Reference
490020
New Start Research Fellowship (2007 - 2011)$1,000,000
Funding
University of Tasmania ($1,000,000)
Scheme
Research Fellowship
Administered By
Menzies Research Institute Tasmania
Research Team
Taylor BVM
Period
2007 - 2011
Menzies Research Institute Senior Fellowship Support - Bruce Taylor (2007 - 2009)$180,000
Funding
MS Society of Tasmania ($180,000)
Scheme
Agreement-Fellowship Support
Administered By
University of Tasmania
Research Team
Taylor BVM
Period
2007 - 2009
Identification of Genes that Influence MS Progression by Pathways that Involve UV Exposure: a Prospective Cohort Study (2006 - 2007)$100,000
Funding
Ian Potter Foundation ($100,000)
Scheme
Grant
Administered By
University of Tasmania
Research Team
van der Mei IAF; Foote SJ; Dickinson JL; Ponsonby AL; Taylor BVM; Dwyer T; Blizzard CL
Period
2006 - 2007
A National MS Prevalence Study (2005 - 2007)$385,000
Funding
The Health Research Council of New Zealand ($385,000)
Scheme
Project Grant
Administered By
University of Otago, Christchurch School of Medicine
Research Team
Taylor BVM; Richardson A; Sabel C; Mason D; Willoughby E
Period
2005 - 2007
Identification of a Gene that Increases Risk of MS Via a Pathway Involving UV Exposure (2005 - 2006)$109,375
Funding
National Health & Medical Research Council ($109,375)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Dwyer T; McKay JD; Dickinson JL; Ponsonby AL; Taylor BVM; Quinn SJ
Period
2005 - 2006
Grant Reference
333105
The seasonal variation in newly diagnosed MS patients cytokine profiles a case control study (2003)$15,000
Funding
Royal Hobart Hospital Research Foundation ($15,000)
Scheme
Project Grant
Administered By
Royal Hobart Hospital
Research Team
Taylor BVM; Stewart N; Walters EH
Year
2003
Correlation of disability, fatigue and depression measures in multiple sclerosis with magnetic resonance imaging measures of lesion load, atrophy and diffusion within normal-appearing white matter (2003)$12,000
Funding
Royal Hobart Hospital Research Foundation ($12,000)
Scheme
Project Grant
Administered By
Royal Hobart Hospital
Research Team
Jones D; McInerney G; Pittas F; Taylor BVM
Year
2003
The Role of Personal UVR Exposure on the Clinical Course of MS: A Prospective Cohort Study (2003 - 2004)$45,000
Funding
Trish Multiple Sclerosis Research Foundation ($45,000)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Ponsonby AL; Dwyer T; Taylor BVM; van der Mei IAF
Period
2003 - 2004
The Australian Multi-Centre Study of Environment and Immune Function (2003 - 2007)$189,413
Funding
National Multiple Sclerosis Society ($189,413)
Scheme
Grant-Research
Administered By
Australian National University
Research Team
Dwyer T; Ponsonby AL; McMichael Tony; van der Mei IAF; Dear K; Kilpatrick T; Taylor BVM; Pender M; Williams D
Period
2003 - 2007
The Role of Personal UVR Exposure on the Clinical Course of MS: a Prospective Cohort Study. (2002 - 2004)$378,000
Funding
National Health & Medical Research Council ($378,000)
Scheme
Grant-Project Three Year
Administered By
University of Tasmania
Research Team
Dwyer T; Ponsonby AL; Taylor BVM; Gies P; McMichael Tony
Period
2002 - 2004
Grant Reference
211308
The Tasmanian Epilepsy Register Health Study (2002)$11,364
Funding
Royal Hobart Hospital Research Foundation ($11,364)
Scheme
Grant-Research
Administered By
University of Tasmania
Research Team
Dwyer T; D'Souza W; Taylor BVM
Year
2002
The role of pro and anti inflammatory cytokines in the progression of multiple sclerosis and the occurrence of relapses of multiple sclerosis and the relationships of cytokine profiles in MS patients to environmental UV exposure and vitamin D metabol (2001)$10,000
Funding
Royal Hobart Hospital Research Foundation ($10,000)
Scheme
Project Grant
Administered By
Royal Hobart Hospital
Research Team
Taylov BVM; Pittas F; Walters EH
Year
2001
Campylobacter project (2001)$17,000
Funding
Royal Hobart Hospital Research Foundation ($17,000)
Scheme
Project Grant
Administered By
Royal Hobart Hospital
Research Team
Taylor BVM; Jones D; Coleman D; Williamson J; McGregor A
Year
2001
Assessment of the cross reactivity between anti campylobacter antibodies and anti ganglioside antibodies in human neuropathic disorders. (2000)$10,000
Funding
Royal Hobart Hospital Research Foundation ($10,000)
Scheme
Project Grant
Administered By
Royal Hobart Hospital
Research Team
Taylor BVM; Williamson J; Luck J
Year
2000
Can infection with campylobacter species cause asymptomatic GBS (1999)$3,500
Funding
Royal Hobart Hospital Research Foundation ($3,500)
Scheme
Project Grant
Administered By
Royal Hobart Hospital
Research Team
Taylor BVM; Jones D; Coleman D; Williamson J; McGregor A
Year
1999
Campylobacteriosis in Tasmania (1998 - 2000)$150,000
Funding
Department of Coummunity & Health Services Tasmania ($150,000)
Scheme
The Dick Buttfield Memorial Fellowship
Administered By
Royal Hobart Hospital
Research Team
Taylor BVM
Period
1998 - 2000

Research Supervision

Current

8

Completed

7

Current

DegreeTitleCommenced
PhDDeterminations of MS Progression2013
PhDComparing Bipolar Disorder and Epilepsy: Neuropsychological Profiles2014
PhDDo MS-associated genetic changes in Vitamin D metabolism affect the function of T cells?2014
PhDImproving the Lives of People with Multiple Sclerosis2015
PhDRisk Factors for People with Primary Progressive Multiple Sclerosis2016
PhDThe Role of LRP1 in Promoting Oligodendrocyte Repair in Multiple Sclerosis2016
PhDHealth-Eonomic Consequences of Multiple Sclerosis in Australia2017
PhDAssociation of Dietary Intake on the Prevalence and Progression of Comorbidities in Multiple Sclerosis2017

Completed

DegreeTitleCompleted
MastersOn the Role of Risk-Associated Genetic Loci in Modulating Clinical Course in Multiple Sclerosis
Candidate: Gongbu Pan
2016
PhDIdentifying Genetic Variants and Environmental Factors Influencing Multiple Sclerosis Pathological Processes
Candidate: Yuan Zhou
2016
PhDThe Role of Serum Lipid Profile and Comorbidities in the Onset and Progression of Multiple Sclerosis
Candidate: Prudence Tettey
2016
PhDLRP Receptors in a Novel Mechanism of Axon Pathfinding and Peripheral Nerve Regeneration
Candidate: Lila Maree Landowski
2014
PhDDissecting the Genetics Architecture of Multiple Sclerosis
Candidate: Rui Lin
2014
PhDOn the Geoepidemiology of Multiple Sclerosis and Environmental and Infectious Determinants of its Clinical Course
Candidate: Steve Lee Simpson Jr
2011
PhDLongitudinal Study of Multiple Sclerosis in Southern Tasmania: Description of Cohort and Impact of Demographic, Disease, Individual and Lifestyle Factors on Clinical Multiple Sclerosis Disability and Progression
Candidate: Fotini Pittas
2009